Biotechnology, Pharmaceutical and Life Science Reports and Courses

Main Pages

    Best Selling Products

    BioNewsCast Press Release Distribution Service

    BioNewsCast Press Release Distribution Service

     

    2nd Annual Vaccine Manufacturing Conference

    2nd Annual Vaccine Manufacturing Conference

     

    Practical Guide to Finding Partners in Pharma & Biotech, 2nd edition

    Practical Guide to Finding Partners in Pharma & Biotech, 2nd edition

     

    Strategic Perspectives: Antidyslipidemics Current market is not conducive for growth

    Strategic Perspectives: Antidyslipidemics Current market is not conducive for growth

     

    Global Antivirals Market Analysis & Forecasts 2008-2023

    Global Antivirals Market Analysis & Forecasts 2008-2023

     

    New Products

    Home Healthcare Market (2009-2014)

    Home Healthcare Market (2009-2014)

     

    Global Dental Consumables Market

    Global Dental Consumables Market

     

    Outsourcing Opportunities in the Medical Device (2009 - 2014)

    Outsourcing Opportunities in the Medical Device (2009 - 2014)

     

    Global Healthcare Information Technology (2009 - 2014)

    Global Healthcare Information Technology (2009 - 2014)

     

    Probiotic Market- Advanced Technologies and Global Market (2009 - 2014)

    Probiotic Market- Advanced Technologies and Global Market (2009 - 2014)

     

    Neurostimulation - Advanced Technologies and Global Market (2009 - 2014)

    Neurostimulation - Advanced Technologies and Global Market (2009 - 2014)

     

    Minimally Invasive and Non Invasive Product and Service Market (2009 - 2014)

    Minimally Invasive and Non Invasive Product and Service Market (2009 - 2014)

     

    Top 10 Medical Device Technologies (2009 - 2014)

    Top 10 Medical Device Technologies (2009 - 2014)

     

    Dental Equipment Market (2009 - 2014)

    Dental Equipment Market (2009 - 2014)

     

    Global Medical Imaging Information System Market

    Global Medical Imaging Information System Market

     

    BioPortfolio - the life science portal
    A comprehensive collection of management reports and services for the life science executive and researcher. Contact Peter Barfoot

  • Markets-and-Markets
  •  Home Healthcare Market (2009-2014)
  •  Global Dental Consumables Market
  •  Outsourcing Opportunities in the Medical Device (2009 - 2014)
  •  Global Healthcare Information Technology (2009 - 2014)
  •  Probiotic Market- Advanced Technologies and Global Market (2009 - 2014)
  •  Neurostimulation - Advanced Technologies and Global Market (2009 - 2014)
  •  Minimally Invasive and Non Invasive Product and Service Market (2009 - 2014)
  •  Top 10 Medical Device Technologies (2009 - 2014)
  •  Dental Equipment Market (2009 - 2014)
  •  Global Medical Imaging Information System Market
  •  Global Ophthalmology Devices & Drugs Market (2009 - 2014)
  •  Diagnostic ECG Market (2009 - 2014)
  •  Drug - Device Combination (2009 - 2014)
  •  Positron Emission Tomography (PET) - Advanced Technologies And Global Market (2009 - 2014)
  •  Magnetic Resonance Imaging (MRI) - Advanced Technologies and Global Market (2009 - 2014)
  •  Food Biotechnology Market
  •  Agriculture Biotechnology Market
  •  Tissue Generation technology Market
  •  Neuroscience Technologies and Global Market (2009 - 2014)
  •  Cardiovascular Therapy - Advanced Technologies And Global Market (2009 - 2014)
  •  Global Injectable Drug Delivery Market
  •  Bioinformatics (2009 - 2014)
  •  Biomarkers- Advanced Technologies and Global Market (2009-2014)
  •  Recombinant Therapies- Advanced Technologies And Global Market (2009 - 2014)
  •  Global RNAi Technology Market (2009 - 2014)
  •  Biochips- Advanced Technologies and Global Market (2009 - 2014)
  •  GPCR - Technologies and Applications (2009 - 2014)
  •  Top 10 Drug Discovery Technologies(2009 - 2014)
  •  Biotech Instrumentation (2009 - 2014)
  •  Cardiac Monitoring - Advanced Technologies and Global Market (2009 - 2014)
  •  Global Stem Cell and Advanced Technologies Market
  •  Biosimilars (2009 - 2014)
  •  Global Biomaterial Market (2009-2014)
  •  US Preterm Infant Care Market (2009-2014)
  •  Global Oncology Pharmaceuticals & Therapeutics Market
  •  Diabetes Market (Devices and Drugs)
  •  Sales Force Effectiveness (2009 - 2014)
  •  HIV/AIDS - Therapies and Global Market (2009 - 2014)
  •  Opportunity Analysis of H1N1 (swine flu) Vaccination Market
  •  Autoimmune Treatment Market (2009 - 2014)
  •  Global Weight Loss and Diet Management Market (2009 - 2014)
  • FIST
  •  CDK Inhibitors Patent Landscape 2009
  •  HIV Therapy Patent Landscape 2009
  •  Malaria Patent Landscape 2009
  • HTStec
  •  Cell-Based Label Free Detection Trends 2009
  •  TR-FRET Based Assay Trends 2009
  •  Primary Cells in Drug Discovery Trends 2009
  •  Next-Gen Sequencing Trends 2009
  •  Sample Prepartion Trends 2009
  •  DOE In Assay Development Trends 2009
  •  GPCR Screening & Profiling Trends 2008
  •  Kinase Screening & Profiling Trends 2008
  •  Automated Biobanking Trends 2008
  •  Live Cell & Kinetic HCS Imaging Trends 2008
  • Avance
  •  Success Rates in Biotech - Going The Wrong Way


  • Scientia Veritas
  •  ScientiaVision Competitor Close-up - Merck and Company, Inc.
  •  ScientiaVision Product Pinpoint - The New Vaccines
  • Donald Macarthur
  •  Orphan Drugs in Asia-Pacific: From designation to pricing, funding and market access
  •  Distribution and Patient Support for Speciality Medicines in Europe
  •  Prospects for Legalizing Drug (Re-)Importation to the United States
  •  Complete Guide to the 2009 PPRS, NICE and other Pharmaceutical Cost Containment Measures in the United Kingdom
  •  Pharmacy Liberalisation in Europe: Prospects and Implications
  •  Access to Hospital Pharmaceutical Markets in the United Kingdom
  •  Pharmaceutical Pricing and Distribution in Japan: The keys to success in the world’s second largest market
  •  Orphan Drugs in Europe: Pricing, Reimbursement, Funding and Market Access Issues
  • Visiongain Conferences
  •  Forced Degradation Strategies Conference
  •  eCTD London Summit
  •  6th Annual Monoclonal Antibodies
  •  Urological Advances 2010 Conference
  •  Bioinformatics Conference
  •  Pre-filled Syringes Americas Conference
  •  Pricing & Reimbursement for Medical Devices Conference
  •  Immunogenicity Summit 2010
  •  Cell-Based Assays
  •  3rd Annual Biomarkers Conference
  •  CNS Clinical Trials
  •  3rd Annual Packaging and Labelling Congress
  •  2nd Annual Vaccine Manufacturing Conference
  •  5th Annual Pharmacovigilance Conference
  •  3rd Annual Lyophilisation
  •  4th Annual Pharmaceutical PLM
  •  6th Annual Biosimilars Conference
  •  5th Annual Drug Delivery Systems Conference
  •  Translational Regenerative Medicine Conference
  • Biopharm Knowledge Publishing
  •  Toxicology and Pharmacology
  •  Outlook 2009 - Global Pharmaceutical and Biotechnology Markets
  •  Quality for Biologics
  •  Virtual Pharma - the radical route to success
  •  EvaluatePharma® Yearbook Company Performance Tables
  •  The Rise of Mid-Sized Pharma
  •  Contract Research Annual Review 2008
  •  Cardiac Toxicity
  •  Biopharm Outsourcing Register
  •  Immunogenicity to Biologics Implications of reactions against biotech drugs
  •  Central and Core Laboratories
  •  Biosimilars - Evolution or Revolution?
  •  Outsourcing Chemistry Services Made Easy
  • Visiongain Reports
  •  Global Pharmaceutical Biotech Market 2010-2025
  •  Influenza Vaccine Market Outlook 2010-2020
  •  The World Antibacterial Treatments Market 2010-2024
  •  The World Dermatological Market Outlook 2010-2024
  •  The US Pharmaceutical Market 2009-2024
  •  Indian Pharmaceutical Market Outlook 2009-2024
  •  Japanese Pharmaceutical Market 2009-2024
  •  The Global Analgesics Market 2009-2024
  •  Monoclonal Antibody Therapeutics 2009-2024
  •  World Neurodegenerative Diseases Market 2009-2024
  •  Chinese Pharmaceutical Market Outlook 2009-2024
  •  World Generics Market 2009-2024
  •  Clinical Trials: World Market 2009-2024
  •  World AMD and Diabetic Retinopathy Pharmaceutical Market 2009-2024
  •  Global Cardiovascular Drugs Market 2009-2024
  •  World Respiratory Disorders Market 2009-2024
  •  World Sleep Disorders Market Analysis 2009-2024
  •  In Vitro Diagnostics: Market Analysis 2009-2024
  •  The Global OTC Pharmaceutical Market 2009-2024
  •  Monoclonal Antibodies in Cancer Therapy 2009-2024
  •  Pharmacovigilance Report and Analysis 2009: Present Challenges and Future Goals
  •  Biosimilars and Follow-On Biologics Report: The Global Outlook 2009-2024
  •  Stem Cells - The Hype and Hope - World Analysis 2009-2024
  •  The Global Multiple Sclerosis Market 2009-2024
  •  Statins: The World Market, 2009-2024
  •  Inflammatory Bowel Diseases: World Market Report 2009-2024
  •  Anti-Obesity Treatments Report - Analysis & Forecasts 2009-2024
  •  World Diabetes Market Analysis, 2009-2023
  •  Smoking Cessation Report, 2009-2024
  •  Ophthalmic Pharmaceuticals, Market Analysis, Forecasts and Dynamics - 2009-2023
  •  The World Dermatological Market Outlook, 2009-2023
  •  Top-10 Biotech Companies - Market Outlook, 2008-2023
  •  World Generics Market, 2008-2013
  •  The Global Pain Market, 2008-2023
  •  The Global Anti-Addiction Market, 2008-2023
  •  World Gastrointestinal Disorders Market 2008-2023
  •  The Japanese Pharmaceutical Market 2008-2023
  •  Women's Reproductive Disorders Therapeutics 2008-2018
  •  Global Antivirals Market Analysis & Forecasts 2008-2023
  •  The Global Vaccines Market 2008-2023
  •  Global Biotech Market Analysis and Forecasts, 2008-2023
  •  Outsourcing for contract manufacturing services 2008-2023
  •  Osteoporosis & Bone Metabolism Disorders Market 2008-2023 Management Report
  •  Pfizer - Market Outlook for a Global Leader, 2008-2013
  •  Therapeutic Monoclonal Antibodies Report 2008-2023
  •  Global Clinical Trial Business Report & Analysis 2008-2018
  •  Oncology Market Leaders - Analyses and Outlook, Market Report 2008-2023
  •  The Pharmaceutical Wholesale and Distribution Industry Outlook and Analysis 2008
  •  In Vitro Diagnostics Market Report and Analysis 2008-2023
  •  Amgen - The Biotech Leader - Market Analyses and Outlook, 2008-2023
  •  The World OTC Pharmaceutical Market Analysis and Forecasts, 2008-2023
  •  The Indian Pharmaceutical Market Analysis and Forecasts 2008-2023
  •  Lipitor Market analysis and forecasts Report 2007-2012 2017 2023
  •  Chinese Pharmaceutical Outlook 2008-2023
  •  Blood Disorders Market Analysis and Forecasts to 2023
  •  Sleep Disorders Market Analysis 2008-2018
  •  Pharma Generic League - Market Analysis and Forecasts 2007 to 2012, 2017 and 2022
  •  The Antibacterial Drug Market Analysis 2008 to 2013
  •  Respiratory Market Insight 2008
  •  The Antipsychotics Market Insight and Analysis 2008
  •  Erectile Dysfunction Market Assessment and Analysis 2007 to 2022
  •  Live-Licensing and In-life testing RandD Processes and Regulation for New Drugs, 2008-2020
  • transB Ltd Nikkei Biotech
  •  Japan BioApproach Database
  • BioInformant Reports
  •  Capitalizing on Opportunities in

    Cord Blood Industry Growth
  •  Choices in Cord Blood Banking: Factors Influencing Parental Decision-Making
  •  Opportunities in Human Embryonic Stem Cell

    (hESC) Products
  •  Neuronal Stem & Progenitors Cells
  •  Mesenchymal Stem Cells, Advances and Applications
  •  Pharmacodynamic Assays Market Report
  •  Stem Cell Research Products: Opportunities Tools and Technologies
  •  Poly(ADP-ribose) polymerase (PARP) Research Products
  • JZMed Reports
  •  China Pharma Outsourcing Annual Review 2009
  •  Innovative Drug Research and Development in China
  •  Top 100 Best Pharma Outsourcing Service Providers in China and India
  •  Comparison of Pharma Outsourcing between China and India
  •  200 China-based Best CROs and CMOs
  •  China Pharma Outsourcing Market By 2015
  •  China's Attraction and Strategies to Work with It Analysis of Best Strategies for Western Pharmaceutical and Biotech Companies to Partner with Chinese Pharmaceutical Companies
  •  Guide to Pharmaceutical Outsourcing in China: A Handbook for Pharmaceutical and Biotechnology Companies Planning to Outsource to China
  • MedMarket Diligence Reports
  •  Worldwide Wound Management, 2008-2017: Established and Emerging Products, Technologies and Markets in the U.S., Europe, Japan & Rest of World
  •  Worldwide Market for Drug-Eluting, Bare and Other Coronary Stents, 2008-2017
  •  Worldwide Surgical Sealants, Glues, Wound Closure and Anti-Adhesion Markets, 2009-2013
  •  Ablation Technologies Worldwide Market, 2008-2017: Products, Technologies Markets, Companies and Opportunities
  •  Worldwide Spine Surgery: Products, Technologies, Markets & Opportunities, 2008-2017
  •  Worldwide Wound Management, 2007-2016: Established and Emerging Products, Technologies and Markets in the U.S., Europe, Japan and Rest of World
  •  Worldwide Market for the Clinical Management of Obesity, 2007-2015
  • Cancer Highlights
  •  Protein Kinase Therapeutics in Oncology - Where to Commercialize?
  •  Currently Druggable in Breast Cancer: A Drug Target Competitive Analysis
  •  Cancer Antibodies: Competitive Positioning for Success
  •  Cancer Vaccines: Aim and Shoot
  •  The Deployment of Antibody Technologies for the Advancement of Cancer Therapeutics
  •  Target Atlas: Competitive Insights to Anti-Angiogenic Drug R&D in Oncology
  •  The Drug Target Atlas of Apoptopic Drugs in Oncology
  • Liang Kong Reports
  •  Drug Registration In China - An overview of China Drug Registration Procedures - version 2009
  •  China HealthCare & Pricing System Reform 2008
  •  How to conduct multinational clinical trials in China
  • CurrentPartnering Reports
  •  Drug Delivery Partnering Agreements in Pharma and Biotech
  •  Partnering Agreements in Diagnostics
  •  Oncology Partnering Agreements in Pharma, Biotech and Diagnostics
  •  Option and Evaluation Agreements in Pharma and Biotech
  •  Royalty Financing Agreements in Pharma, Biotech and Diagnostics
  •  Product and Asset Purchase Agreements in Pharma, Biotech and Diagnostics
  •  Discovery Stage Partnering Agreements in Biopharma
  •  Partnering with Bigpharma
  •  Pre-clinical Stage Partnering Agreements in Biopharma
  •  Clinical Stage Partnering Agreements in Biopharma
  •  Manufacturing and Supply Agreements in Biopharma - 2nd Edition
  •  Distribution Agreements in Biopharma
  •  Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics, 2nd edition
  •  Merger and Acquisition Agreements in Biopharma
  •  Bigpharma Partnering Agreements
  •  Practical Guide to Finding Partners in Pharma & Biotech, 2nd edition
  • Insight Pharma Reports
  •  STRATEGIC ALLIANCES: Synergistic Path to Value Creation
  •  

    Multiplex Assays: Evolving Technologies, Applications and Future Directions Report Overview


  •  Inflammatory Disorders: Therapies That Suppress or Balance the Immune Response Overview
  •  Immunotherapies and Vaccines for Nontraditional Indications
  •  Ion Channel Modulator Pipelines: Targets and Agents in Development
  •  Monoclonal Antibodies: Pipeline Analysis and Competitive Assessment 2009
  •  Outsourcing Preclinical Studies to China: Benefits and Challenges
  •  Data Mining in Drug Development and Translational Medicine
  •  

    Bioinformatics and Computational Biology: Bottlenecks and Options
  •  Pharmacogenomics: Delivering on the Promise
  •  Approaches to Reducing Phase II Attrition
  •  Direct-To-Consumer Genetic Testing: Business Prospects in the United States
  •  Medicinal Chemistry for Drug Discovery: Significance of Recent Trends
  •  Protease Inhibitors: Innovation Drives Drug Pipeline
  •  Molecular Diagnostics: A Dynamic and Rapidly Broadening Market
  •  Conducting Clinical Trials in Europe: An Insider’s Analysis
  •  Neurodegenerative Diseases: Next-Generation Drugs for Four Major Disorders
  •  Biomedical Imaging: From Drug Target Discovery to Medical Diagnostics
  •  European Clinical Trial Site Options: An Insider’s Analysis Overview
  •  Stem Cells Come of Age Report Overview
  •  Immunotherapies and Vaccines for Cancer and Infectious Diseases Report Overview
  •  GPCRs: Dawn of a New Era?
  •  Obesity Drug Pipeline: Developing Therapies for a Complex Disease
  •  Strategic Management of Resources and Portfolios: Structuring Risk to Maximize Opportunity in Pharmaceutical R&D
  •  Cancer Biomarkers: Adoption Is Driving Growth
  •  Antibiotic R&D: Resolving the Paradox between Unmet Medical Need and Commercial Incentive
  •  Systems Biology: A Disruptive Technology
  •  Blood-Brain Barrier: Bridging Options for Drug Discovery and Development
  •  Cardiotoxicity: Issues, Technologies, and Solutions for the Future
  •  INFLAMMATORY DIRECTIONS Strategies for Six Diseases with Unmet Needs
  •  MicroRNAs Commercial Products on the Horizon
  •  Epigenetics Technologies, Applications, and the Commercial Landscape
  •  Multiplex Assays in Translational Medicine Technologies, Applications, and Future Directions
  •  Molecular Imaging in Drug R and D and Medical Practice Technologies, Applications, Markets
  •  Ophthalmological Therapeutics Pipelines, Delivery Technologies, and Markets
  • Best Practices Reports
  •  Performance Benchmark: Optimizing Staff Levels to Drive Growth in Medical Devices


  •  Shaping the Marketplace to Support Successful Oncology Product Launches


  •  Collaborating with Patient Advocacy Groups to Educate the Marketplace


  •  Developing Managed Care Pull-Through Excellence
  •  Managed Markets Account Management: Assessing the Performance of Account Executives
  •  Innovations in Patient-Focused Initiatives: Case Studies in Reaching, Engaging and Supporting Patients
  •  Best Practices in Recruitment for Medical Education Programs
  •  Best Practices for Post-Marketing Surveillance of Adverse Events within the U.S.
  •  Best Practices for Internal Communications Regarding Brands and Disease States
  •  Serving the Healthcare Needs of Employers: Employer Market Strategies and Tactics
  •  Medical Affairs Resources, Structures and Trends
  •  Best Practices in Utilizing Health Outcomes Data for Promotional - Commercial Efforts
  •  Understanding Managed Markets: Effective Market Research Structures & Activities to Maximize Payers Access & Insights
  •  Managing Sales Training to Accelerate Speed to Productivity
  •  Best Practices in Designing Effective Brand Teams: Brand Governance and Brand Team Management
  •  Managed Markets Market Research: Effective Structures & Activities for Gaining Maximum Payer Access & Insight
  •  Pharmaceutical New Product Commercialization: Preparing for Market Success
  •  Pharmaceutical Competitive Intelligence Excellence: Optimizing Data Collection Within Approved Guidelines
  •  U.S. Sales Communications Excellence: Resources, Structure and Processes to Optimize Pharmaceutical Sales Communications
  •  Rewarding & Recognizing Top-Performing Sales People
  •  Educating the Market: Creating Value Through Support of Continuing Medical Education
  •  Maintaining a Competitive Edge in Pharmaceutical Public Affairs: Benchmarking the Resources Required to Serve the U.S. Market
  •  Delivering Maximum Brand Impact Via Pharmaceutical Market Analytics
  •  Building and Sustaining Impactful Competitive Intelligence Organizations
  •  Pharmaceutical Sales Training: Turning New Hires into Top Performers
  •  Cross-Industry Field Sales Force Excellence
  •  Hiring Top Talent: Best Practices in University Recruiting
  •  HR Resourcing Excellence Series
  •  Managing Cross-Functional Teams for Pharmaceutical Product Commercialization Excellence
  •  Integrating Quality into Business Systems for High Performance
  •  Pharma Sales Force Effectiveness: Increasing Productivity Through Streamlined Internal Communication
  •  Scientific Publications Strategy: Managing Reputation, Clinical Trial Results and Commercial Relevance
  •  Requip Case Study: Life Cycle Management - Reinvigorating a Mature Brand
  •  Cymbalta Case Study: Successfully Entering a Crowded Market with a New Mechanism of Action
  •  The High Performing Pharmaceutical District Sales Manager: Current Trends & Future Directions
  •  Clinical Trial Excellence: Toolkit for Winning Investigators in a Competitive Marketplace
  •  Pharmaceutical New Product Planning: Structure and Activities to Drive Growth and Profitability
  •  Rituxan Case Study: Pre-Launch Communications to Change the Dominant Treatment Paradigm
  •  Byetta Case Study: Using Medical Education as a Springboard for Product Launch
  •  Pharmaceutical Science Exellence: CMC Activities, Resources, and Performance
  •  Public Relations Excellence: Using PR to Launch, Grow, and Extend Your Brands
  •  Product Commercialization Excellence: Preparation and Management of Fixed-Dose Combination Drug Products
  •  Nexium Case Study: Using Public Relations to Reach Diverse Patient Populations and Build Bridges Between Product Generations
  •  Slentrol Case Study: Using Integrated PR Tactics to Support a Product Launch
  •  Pharmaceutical Product Launch Evaluation Excellence: Processes & Measures to Evaluate Launch Success
  •  Competitive Intelligence Policies, Ethics and Data Collection: Navigating the Gray Zone
  •  Performance Benchmark: Optimizing Marketing Staff Levels to Drive Growth
  •  Best Practices for Valuing Internal Consulting Organizations
  •  Winning Brand Team Management: Best Practices in Leadership, Work Practices, Structure and Performance Management
  •  Building an Effective Regulatory Relationship with the FDA
  •  Using Public Relations to Launch, Grow and Extend Your Brands
  •  Medical Science Liaisons: Gaining Access and Forging Relationships with Key Opinion Leaders
  •  Optimizing Key Opintion Leader Relationships: Best Practices in KOL Management
  • VennBio Reports
  •  Hypertension: Treatments and Prescribing Practices - A Global Survey
  •  Stroke: Treatments and Prescribing Practices - A Global Survey 2009
  •  Treating Neuropathic Pain - A Global Study of Clinical Strategies
  •  Alzheimer's Disease Biomarkers, 2009
  •  Cancer Drug Resistance
  •  Peripheral Neuropathy and Neuropathic Pain, 2008
  •  Antibiotics and Drug Resistance 2008
  •  Targeting Cancer Stem Cells: Therapeutic Strategies and Pipeline Developments (2010)
  • PharmaVentures Reports
  •  The Royalty Rate Report 2010: A Comprehensive Assessment of Valuation in the Pharmaceutical Sector
  •  Analysis of Oncology Deals: Trends in Deal Structures and Valuations
  •  Trends in Pharmaceutical Deal Making: An Analysis of Valuations, Deal Structures and Deal Types
  •  PharmaDeals Review
  •  Guide to Valuation of Pharmaceutical Licensing Deals
  •  Pharmaceutical Deal Types - The Essential Guide for Deal Makers
  •  Effective Deal Making in Drug Delivery
  •  The Royalty Rate Report 2009: A Comprehensive Assessment of Valuation in the Pharmaceutical Sector
  •  Competition Law and Intellectual Property Strategy in the Pharmaceuticals Sector
  •  Pricing and Reimbursement Risk and Opportunity in Pharmaceutical Deal Making
  •  Valuing and Structuring Pharmaceutical Licensing Agreements
  •  Nanotechnology-Based Drug Delivery Systems in Japan
  •  Strategies and Tactics for Successful Partnering
  • BioInformatics Reports
  •  

    The Contract Research Market for Drug Discovery Technologies: Opportunities for Life Science Suppliers
  •  

    The Market Outlook for Research Products in FY2010
  •  New Media Marketing Channels: Creating Effective Online Life Science Promotional Videos
  •  

    Exploring the Epigenetics Market: Opportunities for Product Placement and Innovations
  •  

    The Market for Antibodies: Keys to Success for Commercial Suppliers, Vol. III
  •  Capitalizing on New Opportunities for Stem Cell Products
  •  Prospering in a Down Market: Strategies for Life Science Suppliers
  •  The Brave New World of Scientific Publishing
  •  Protein Research: Strategies for Marketing to Chemists and Biologists
  •  Instrumentation Service Contracts: Opportunities for Differentiation
  •  Understanding Switching Dynamics: Maximizing Customer Retention in the Life Sciences
  •  Life Science Product Catalogs Techniques to Increase Sales
  •  Conference and Exhibit Strategies in the Life Sciences What’s Working Now
  •  Advertising to Life Scientists Resolving the Print vs. Online Dilemma
  •  Marketing to Life Scientists Capturing Customers Attention in Applied Markets
  • Kalorama Reports
  •  Electrical and Magnetic Neurostimulation: Applications, Technologies, and Market Potential
  •  SNP Genotyping and Analysis Markets 2010
  •  EMR 2010 (Market Analysis, ARRA Incentives, Key Players, and Important Trends)
  •  Obesity, Weight Loss and Diet Management Markets (Pharmaceutical, Surgical and Dietary Approaches)
  •  Medical Imaging Markets: Contrast Agents
  •  Point of Care Diagnostics 2010 and Beyond: Rapid Testing at a Crossroads
  •  

    Veterinary Diagnostics Markets
  •  2009 Worldwide Diagnostics Market Research Bundle
  •  The Worldwide Market for Anti-Infectives (Antifungals, Antibacterials and Antivirals)
  •  The Market for Wellness Programs and Their Impact on Pharmaceutical, Diagnostic and Device Product Markets
  •  Drug Delivery Markets: Implantable - Injectable and Needle-Free Delivery Systems
  •  

    Healthcare Computer System Markets and Trends In HIT Buying
  •  Medical Imaging Markets: MRI (Magnetic Resonance Imaging) and Ultrasound
  •  Infectious Disease Diagnostic Markets
  •  Implant-Based Dental Reconstruction: World Dental Implant and Bone Graft Market, 3rd Edition
  •  The World Market for Biosimilars and the Potential for US Follow-on Biologics
  •  DNA Sequencing Equipment and Services Markets, 2nd Edition
  •  Healthcare Computer System Markets and Trends In HIT Buying (Forecasts for System, Service and Support Revenues, Areas of Interest, Major Competitor Profiles)
  •  Who is Who in Clinical Diagnostics in India (Markets, Distributors, Companies, Countr Overview)
  •  Advances in Ophthalmology: Markets in the Treatment of Eye Disorders and Corrective Vision, 2nd Ediiton
  •  Drug Delivery Markets: Oral Delivery
  •  

    Worldwide Wound Care: Total Market Coverage (Vols. I-III: Skin Ulcers, Burns, Surgical and Trauma Wounds), 4th Edition
  •  

    Wound Care Markets, 4th. Edition, Vol. III: Surgical and Trauma Wounds
  •  Who is Who in Clinical Diagnostics in China (Manufacturers and Distributors Profiles, Market, Industry Overview
  •  High-Tech Patient Monitoring Systems Markets (Remote and Wireless Systems, Data Processing, EMR Data Transfer)
  •  What is Working in IVD: Successful Commercialization of New Products and Technologies
  •  In Vitro Diagnostics in a Recessionary Economy: IVD Market Forecasts, Analysis and Success Strategies


  •  Vaccines 2009: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry
  •  H1N1 (Swine Influenza) Market Assessment (Latest Data, Company Profiles, Implications for Immunoassays and Molecular Assays)
  •  World Veterinary Health Products (Animal Pharmaceuticals, Vaccines, OTC and Performance Enhancers)
  •  Rx to OTC Switches 2009
  •  The World Market for Cancer Therapeutics and Biotherapeutics, 3rd. Edition
  •  Cell Culture: The World Market for Media, Sera and Reagents, 2nd Edition
  •  Pharmacodiagnostics and Personalized Medicine 2009 (Markets, Challenges, Forecasts and Key Players)
  •  Wound Care Markets, 4th. Edition, Vol. II: Burns
  •  Wound Care Markets, 4th. Edition, Vol. I: Skin Ulcers
  •  Medical Beds and Medical Chairs
  •  Contract Manufacturing in Orthopedics Devices: Markets for Hip and Knee Implants
  •  World Markets for Point of Care Diagnostics 2009-13
  •  Who's Doing What in Molecular Diagnostics? - The Results of the Kalorama Information/Emmes Group Survey of U.S. Laboratories
  •  World Market for Dialysis Equipment and Services
  •  Pharmaceutical Markets in India
  •  Healthcare in a Recession (OTC, Generics, Out of Pocket Spending, Healthcare Legislation, Retail Clinics, Outsourcing and Other Topics)
  •  Retail Clinics and the In-Store Healthcare Market 2009: Bright Spot in the Current Economy?
  •  Liquid Chromatography Markets (LC, HPLC and UHPLC)
  •  Stem Cell Therapeutics Markets
  •  Medical Device Bundle (Infusion Pumps, Reusable Devices, Minimally Invasive Surgical Devices, Catheters, OEM Finished Medical Products)
  •  U.S. Markets for EMR (Electronic Medical Records) Technology
  •  Medical Imaging Markets, Volume I: Radiography (X-Ray, Digital X-Ray, Fluoroscopy, Mammography, and CT Markets)
  •  The World Market for Molecular Diagnostics
  •  Clinical Nutrition Products: World Markets, 3rd Edition
  •  Women's Health: Worldwide Prescription Drug Markets
  •  Nosocomial Infections: Market Impact on Diagnostics and Therapeutics: (MRSA, HAP, C. diff and other Hospital Acquired Infections)
  •  The World Market for Gastrointestinal Endoscopy Equipment
  •  Pharmaceutical Outsourcing Opportunities Post-Launch: Contract Manufacturing and Contract Sales and Marketing, 3rd Edition
  •  The Clinical Laboratory Services Market (Growth Opportunities, Competitive Analysis and Competitor Profiles)
  •  Protein Therapeutics: Monoclonal Antibodies, Plasma Proteins, Vaccines, and Other Treatments, Global Market
  •  Emerging Cancer Vaccines: Market Forecasts, New Developments and Pipeline Analysis, 3rd Edition
  •  Biophotonics: A Strategic Assessment of Photonics Technologies for Biomedical Applications, 2nd Edition
  •  Effective Competitive Intelligence: A "How-To" Guide for Life Science Companies
  •  Key Genetic Technologies Market Research Bundle (SNPs, Gene Expression Profiling, DNA Sequencing and Biochips)
  •  Hernia Repair Device Markets and Procedures
  •  Blood: The Worldwide Market for Blood Products, Blood Testing, Blood Equipment, and Synthetic Blood Products
  •  Reusable Medical Devices and Instruments
  •  Outsourcing in Drug Development: The Contract CRO Market, 3rd Edition
  •  Glucose Testing Markets
  •  HIV: Markets for Diagnostics and Therapeutics
  •  Contract Manufacturing Opportunities in High-Growth Medical Devices (Catheters, Pacemakers, LVADs, Hip and Knee Implants, Air Pathways, Syringes)
  •  Infusion Pump Markets (Large Volume, Ambulatory, Disposable, Syringe, and Specialty Infusion Pumps)
  •  Minimally Invasive Surgical Devices, World Market
  •  Worldwide Diagnostics Market Research Bundle (Worldwide Market for In Vitro Diagnostic Tests 6th Ed., SNP Genotyping and Analysis Markets, Companion Diagnostics Markets)
  •  World Market for Respiratory Equipment and Disposables, 3rd. Edition
  •  The World Alzheimer's Disease Market (Incidence, Treatments, Key Companies, Pipeline and Trends)
  •  Diagnostic Test Service Commercialization in Multiplex and Esoteric Testing: A Roadmap to Diagnostics in the 21st Century
  •  Facial Rejuvenation Markets Worldwide
  •  Lab Automation Markets Worldwide (Next-Generation Systems, Key Companies, Forecasts and Trends)
  •  Companion Diagnostics Markets (A Realistic Assessment of the Opportunities, Challenges, Key Players and Important Trends in Personalized Medicine)
  •  SNP Genotyping and Analysis Markets
  •  Kalorama Annual Subscription
  •  The Long-Term Care Market: Nursing Homes, Home Care, Hospice Care, and Assisted Living
  •  Pharmaceutical Markets in Brazil, Russia, India and China ( BRIC nations )
  •  The Worldwide Market for In Vitro Diagnostic Tests, 6th Edition
  •  Major World Markets for Stents and The Economics of Drug-Eluting Technology
  •  Outsourcing in Drug Discovery, 3rd Edition
  •  Wireless in Healthcare 2008 (The Market for Bluetooth, RFID, Zigbee, UWB WWAN, WMAN, WLAN and other technologies)
  •  World OTC Pharmaceutical Markets: Self-Medication, Developing and Petro-Rich Economies, BTC and Other Growth Trends
  •  World Wound Care Markets 2008
  •  Biogenerics, World Market
  •  The Return of the Rx to OTC Switch Market Analysis and Product Management Strategies
  •  The Vaccines 2008 World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry
  •  Key Topics in Pharmaceutical Market Strategy 2008 (Drug Pricing, Rx to OTC switches, Retail Clinics, Prescribing Pharmacists, The Growing Out of Pocket Healthcare Market)
  •  RFID in Pharmaceutical Manufacturing
  •  Stem Cells Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development
  •  The Return of the Rx to OTC Switch: Market Analysis and Product Management Strategies
  •  The Worldwide Market for Cancer Diagnostics, 3rd Edition
  •  High-Tech Patient Monitoring Systems Markets (Remote and Wireless, Patient Data Processing, EMR Data transfer/interface Systems)
  •  Congestive Heart Failure: Major World Markets, Volume II: Devices (Pacemaker, ICD, LVAD and Artificial Heart Markets)
  •  Worldwide Market for Rheumatoid Arthritis and Lupus Treatments (Autoimmune Disease Markets)
  •  Pharmaceutical Excipients for Oral Formulations 2nd Edition
  •  Molecular Diagnostics in China
  •  The World Market for Catheters
  •  Prescription Dermatological Drugs: Worldwide Market, 6th Edition
  • Business Insights
  •  Nanotechnology in Healthcare: Market outlook for applications, tools and materials, and 40 company profiles
  •  DNA Sequencing In Drug Discovery: Market outlook for applications, tools and services, and 40 company profiles
  •  Innovations In Epigenetics: Advances in Technologies, Diagnostics & Therapeutics
  •  Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
  •  The Future of R&D Outsourcing: Investigating development hurdles, key challenges & strategies to optimize CRO relationships
  •  Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
  •  The CRO Market Outlook: Emerging markets, leading players and future trends
  •  Emerging Clinical Trial Locations: Market dynamics and the changing healthcare and regulatory environment
  •  The CNS Market Outlook to 2014: Competitive landscape, pipeline analysis and growth opportunities
  •  Opportunities in Orphan Drugs: Strategies for developing maximum returns from niche indications
  •  The Japanese Pharmaceutical Market Outlook to 2014: Policy environment, market structure, competitive landscape, growth opportunities
  •  The Turkish Pharmaceutical Market Outlook to 2014: Policy environment, market structure, competitive landscape, growth opportunities
  •  The Cancer Market Outlook To 2014: Competitive landscape, market size, pipeline analysis and growth opportunities
  •  The Gastrointestinal Market Outlook To 2014: Market dynamics, competitive landscape, emerging therapies
  •  Latin American Pharmaceutical Market Outlook To 2014: Policy environment, market analysis, forecasts and growth opportunities
  •  Pharma Pricing and Reimbursement Outlook: Optimizing price and market access in a recessionary climate
  •  The CMO Market Outlook: Emerging markets, key players and future trends
  •  Innovations in Oncology Diagnostics: Technological advances, growth opportunities and future market outlook
  •  Advances in the Stem Cell Industry: The future impact of innovation, and an evaluation of the commercial landscape
  •  Optimizing Lifecycle Management: Maximizing commercial lifespan through label expansion and combination products
  •  The Global Bioinformatics Market: Market size, forecasts and company profiles
  •  The Future of the Biodefense Industry: Regulation, funding opportunities and company profiles
  •  The Diabetes Market Outlook To 2014: Market dynamics, competitive landscape, emerging therapies
  •  The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities
  •  Impact of Counterfeits on Parallel Trade & Pharmaceutical Distribution: Issues, initiatives and insights for supply chain integrity
  •  Generics Growth Strategies: Cost containment and M&A shape the global generics industry
  •  The Ophthalmic Pharmaceutical Market Outlook To 2014: Competitive landscape, pipeline analysis, growth opportunities and market forecasts
  •  Launching Next Generation Oncology Products: Evolving Strategies in a Payor’s Market
  •  Pharmaceutical Sales Force Effectiveness Strategies: Evaluating evolving sales models & advanced technology for a customer centric approach
  •  Expanding Applications of Personalized Medicine: Use of biomarkers in prognostic, predictive and pharmacogenetic tests in a targeted approach
  •  Accelerating Lead Generation: Emerging technologies and strategies
  •  Innovations in Protein Kinase Therapies: Company pipelines, therapeutic applications and market forecasts
  •  Early Stage Drug Safety Strategies and Risk Management: Maximizing opportunities towards achieving clinical success
  •  R&D Cost Cutting: Managing cost containment and safeguarding productivity
  •  The Vaccines Market Outlook To 2014: Competitive landscape, pipeline analysis, growth opportunities and market forecasts
  •  The Chinese Hospital Pharmaceutical Market Outlook To 2014: Policy environment, healthcare system, market structure, competitive landscape, growth opportunities
  •  The Top 10 Pharmaceutical Companies in India: Growth strategies, performance and SWOT analyses
  •  The Indian Pharmaceutical Market Outlook To 2014: Market trends, key players, forecast
  •  The Pain Management Market Outlook To 2014: Competitive landscape, pipeline analysis and growth opportunities
  •  Biotech Exit Strategies: Delivering value to investors in a challenging funding market
  •  The US Pharmaceutical Market Outlook To 2014: Market trends, leading players and forecasts
  •  The Eastern European Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities
  •  Intellectual Property and Outsourcing in China: Minimizing risk whilst maximizing return on investment
  •  The Top 10 Biosimilar Players: Positioning, performance and SWOT analyses
  •  The Top 10 Contract Research Organizations: Positioning, performance and SWOT analyses
  •  The Future of Biobanks: Regulation, ethics, investment and the humanization of drug discovery
  •  The Autoimmune Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
  •  The Asian Cardiovascular Market Outlook to 2014: Regional and therapeutic analysis, pipeline impact and growth opportunities
  •  The Canadian Pharmaceutical Market Outlook to 2013: Policy environment, market structure, pipeline analysis, growth opportunities
  •  The Scandinavian Pharmaceutical Market Outlook to 2013: Policy environment, market structure, pipeline analysis, growth opportunities
  •  Evolving Trends in Biopharmaceutical Licensing: Deal assessments, drivers and resistors
  •  Technology Transfer Strategies: Maximizing the returns from new technologies
  •  Negotiating the Emerging Biosimilars Landscape: Key developments in the regulatory environment
  •  Delivery Mechanisms for Large Molecule Drugs: Successes and failures of leading technologies and key drivers for market success
  •  The Cardiovascular Market Outlook to 2013: Competitive landscape, global market analysis and pipeline analysis
  •  The Cancer Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
  •  The Pharmaceutical Market Outlook to 2018: Key threats and opportunities for Big Pharma and its responses to them
  •  The Top Ten Specialty Pharmaceutical Companies: Positioning, performance and SWOT analyses
  •  The Promotional Landscape in US and Europe: Benchmarking promotional ROI and optimizing detailing and journal spend
  •  Biotech M&A Strategies: Deal assessments, trends and future prospects
  •  The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
  •  Successful Pharmabiotech Alliance Strategies: Driving synergies, avoiding failure and managing relationships
  •  The CNS Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
  •  Innovative Strategies and Models for R&D Success: The evolving networked pharma company
  •  Innovations and Pipelines for Respiratory Disorders: Niche markets, new products and future developments
  •  The Anti-Infectives Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
  •  The Top 10 Generic Pharmaceutical Companies: Positioning, performance and SWOT analyses
  •  Valuing Pharmaceutical Innovation: Pricing and reimbursement for innovative therapies
  •  Obesity Drug Markets in the US and EU: Analysis of product pipelines and the competitive environment
  •  Contract Manufacturing Strategies - Market developments, technology transfer and key success factors
  •  The Emerging Role of Postmarketing Clinical Research - Regulatory issues, strategic drivers and overall trends
  •  Innovative Clinical Trial Design and Management - Trends, success stories and impact upon R&D budgets
  •  Innovations in The Management of Diabetes - Next generation treatments and market dynamics
  •  Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
  •  The Convergence of Biomarkers and Diagnostics: Therapy area analyses, key products and future trends
  •  Drug Approval Trends at the FDA and EMEA: Process improvements, heightened scrutiny and industry response
  •  The Fastest Growing Biotechnology Companies: Growth strategies, comparative analyses and company profiles
  •  Impact of Pharmacogenomics on Public Healthcare Policy Educating patients, payors and healthcare providers
  •  The Future of Targeted Therapeutics Key technologies, new therapy area applications and leading players
  •  Heart Health Food and Drinks NPD in cardiovascular health, hypertension and cholesterol reduction
  •  Nanotechnology Revolutionizing R&D to develop smarter therapeutics and diagnostics
  •  Innovations in Bioinformatics Emerging tools for drug discovery and development
  •  The Cardiovascular Disorders Market Outlook to 2012
  •  Launching Combination Products: Brand extension and franchise development strategies
  •  The Cancer Market Outlook to 2012
  • Datamonitor Healthcare Reports
  •  Biotechnology: Global Industry Guide 2009
  •  Commercial Insight: Anticonvulsants - Non-epilepsy label expansions provide blockbuster potential
  •  Commercial Insight: Antidepressants - Novel mechanism offers hope in depressed market
  •  Commercial Insight: Antidiabetics - DPP-IV inhibitors poised to sweep the market
  •  Commercial Insight: Antidiabetics in Australia - Reimbursement status shapes novel classes
  •  Commercial Insight: Hormonal Contraceptives - Look beyond oral contraception for a competitive edge
  •  Commercial Insight: Parkinson's Disease - Japan and Europe to drive total market growth
  •  Generics: Global Industry Guide
  •  Hormonal Contraceptives Market Forecast
  •  Orphan Drug Strategies
  •  Orthopedics: Global Industry Guide 2009
  •  Parkinson's Disease Market Forecast
  •  Pipeline Insight: Disease Modification in Rheumatoid Arthritis - New drug targets compete in crowded market
  •  Pipeline Insight: HIV - The Age of Convenience
  •  Stakeholder Insight: Acute Leukemias - Reaching the limits of cytotoxic chemotherapy
  •  Top 20 Cancer Therapy Brands Forecast
  •  Monoclonal antibodies: 2009 update
  •  Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
  •  Emerging Markets Series: Indonesia and Philippines
  •  Commercial Insight: Antipsychotics - Revenues of depots and new agents will partially offset generic erosion
  •  Pipeline Insight: Colorectal Cancer - Growing trend towards personalized medicine
  •  Healthcare: Global Industry Guide
  •  Opioids Market Forecast
  •  Stakeholder Opinions: Tuberculosis - Development pipeline shows signs of life
  •  Stakeholder Opinions: Back Pain - Gain competitive edge by targeting subpopulations
  •  Stakeholder Opinions: Pulmonary Arterial Hypertension clinical community builds order from chaos
  •  Pipeline and Commercial Insight: Nicotine Dependence - Chantix issues overshadow vaccine potential
  •  Forecast Insight: Opioids - Saturation limits the commercial potential of individual brands
  •  Stakeholder Opinions: Pancreatic Cancer - Gemzar dominance will continue among high levels of persistent unmet needs
  •  Generic Benchmarking: Brand Erosion at Patent Expiry
  •  Stakeholder Insight: Psoriasis - Biologics are yet to make topical treatments obsolete
  •  Stakeholder Opinions: Cystic Fibrosis - A pipeline full of hope
  •  Stakeholder Opinions: Physician perception of biologics in autoimmune disease - Targeted detailing is the key to success
  •  Orthopedics: Global Industry Guide 2008
  •  Biotechnology: Global Industry Guide 2008
  •  Stakeholder Insight: Infertility - Undifferentiated drugs force need to strengthen prescriber and payer relationship
  •  Forecast Insight: Antithrombotics - Market growth dependent on new agents
  •  Pharmaceutical Company Outlook to 2013
  •  Commercial Insight: Rheumatoid arthritis - Anti-TNFs defend first-line biologic position despite competition
  •  Pipeline and Commercial Insight: Hepatitis C - High unmet need drives rapid innovation
  •  Commercial Insight: Community Antibacterials - Pipelines wither as generic tidal wave takes its toll
  •  Commercial Insight: Solid organ transplantation - The impact of new biologics, generics and reformulations
  •  Infectious Diseases Vaccine Market Overview: Key Companies & Strategies - In times of crisis, Big Pharma turns to vaccines
  •  Forecast Insight: Depression - Generic induced brand erosion leads to market decline
  •  Forecast Insight: Migraine - Generic incursion inhibits market growth
  •  Forecast Insight: Epilepsy - Future market upgrade following new drug launches
  •  Stakeholder Insight: Spondyloarthropathies - Disease perception limits market potential
  •  Stakeholder Opinions: Sarcomas
  •  Stakeholder Insight: Acute Coronary Syndromes ACS in Europe, what is the best practice?
  •  Pipeline Insight: Cancer Overview - Gastrointestinal, Skin, Sarcomas
  •  Biotech Financing in the Credit Crisis: Strategies for a radically altered landscape
  •  Stakeholder Opinions: Narcolepsy - Entry-point to a lucrative fatigue-associated market
  •  Divestment Strategies: Pharma is divesting in order to grow
  •  Pricing and Reimbursement in Key Asia Pacific Markets
  •  Stakeholder Opinions: Type 2 Diabetes in the UAE & Saudi Arabia Growth opportunities in fragmented markets
  •  Generics: Global Industry Guide 2008
  •  Health Care Equipment & Supplies: Global Industry Guide
  •  Stakeholder Opinions: Diabetic Renal Disease
  •  Pipeline Insight: Non-Insulin Antidiabetics - Incretin mimetics, leaders in a diverse pipeline
  •  RNA therapy: the next big thing after monoclonal antibodies?
  •  Commercial Insight: Pain Market Overview - Non-traditional analgesics and opioid reformulations to sustain sector growth
  •  M&A trends in Pharma
  •  Strategic Perspectives: Antidyslipidemics Current market is not conducive for growth
  •  Emerging Markets Series: The Pharmaceutical Market of South Korea
  •  Pipeline and Commercial Insight: Schizophrenia - Second generation depots protect market value
  •  Sales Force Effectiveness
  •  Stakeholder Insight: Osteoporosis - Generic alendronate further establishes oral bisphosphonates as gold standard
  •  Trends in Pharmaceutical Portfolio Management - Strategies to maintain profitability despite adversity
  •  Trends in Clinical Trials: Strategies to enhance clinical trial design
  •  Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor types
  •  Stakeholder Opinions: Vaccine adjuvants - uncertainties rule
  •  Forecast Insight: Parkinson's Disease - Market upgrade following evidence of disease slowing with Azilect
  •  Commercial Insight: Inflammatory Bowel Disease - Convenience and compliance drive market success
  •  Forecast Insight: Dyslipidemia - Genericization and negative trial data drive market shrinking
  •  Commercial Insight: Select herpes viruses and human papilloma virus - Non-biologic interventions for oral and genital herpes, cytomegalovirus infection, herpes zoster and genital warts
  •  Forecast Insight: Antidiabetics - Switching to new molecule antidiabetics drives market growth
  •  Big Pharma M&A Analysis to 2012 - Surveying the growth rate landscape
  •  Commercial Insight: HIV - The battle for market share is getting fiercer
  •  Forecast Insight: Insomnia Orexin and serotonin receptor modulators to innovate market
  •  Commercial Insight: Antihormonal Therapy Cancer Brands - Careful lifecycle management needed to preserve brand dominance
  •  Commercial Insight: Top 20 Therapy Cancer Brands - Key brands set to consolidate advantage as competition intensifies
  •  Forecast Insight: Multiple Sclerosis - Tysabri to prevail despite safety setbacks
  •  Forecast Insight: Asthma/COPD - Little long-term future for long-acting single-agent inhalers?
  •  Biosimilars Series: Stakeholder Analysis
  •  Forecast Insight: Antihypertensives Key patent expiries prevent market growth
  •  Pipeline Insight: Cancer Overview - Lung, Brain, Head and Neck, Thyroid
  •  Commercial Insight: Targeted Therapy Cancer Brands - High growth market will see eight new blockbusters by 2017
  •  Commercial Insight: Cytotoxic Therapy Cancer Brands - Looming patent expiries limit market growth
  •  Generic Series: Optimizing Brand Lifecycle Management Winning Strategies to Maximize Revenue in the Face of Growing Generic Competition
  •  Pipeline Insight: Insulin antidiabetics - Return to injections alternative delivery methods fall by the wayside
  •  Stakeholder Opinions: Diagnostics in Neurology - Predictive biomarkers expand drug revenues
  •  Stakeholder Opinions: Novel Therapeutic Approaches in Cardiovascular Medicine - Lack of market prospects for biologics expose an opportunity for cell and gene therapies
  •  Commercial and Pipeline Insight: Fibromyalgia - Approvals legitimize condition and expose underserved patient population
  •  Commercial and Pipeline Insight: Vaccines for Adults and the Elderly - New blockbuster opportunities ahead
  •  Stakeholder Insight: Asthma - Over-prescribing is common in intermittent and mild forms of asthma
  •  Monoclonal Antibodies Report: 2008 Update
  •  Pipeline and Commercial Insight: Neuropathic Pain - UCB's Vimpat set to compete with major players
  •  Stakeholder Opinions: Non-hormonal Treatments for Menopausal Symptoms - Market open to takers as tepid pipeline fails to meet demand
  •  Rx-to-OTC Strategies: Maximizing the Commercial Potential of an Rx-to-OTC Switch
  •  Drug Repositioning Strategies - Serendipity by design
  •  Forecast Insight: Osteoarthritis - The COX-2 pipeline collapses
  •  Pipeline Insight: Acute Stroke: Commercial risk offsets high unmet need
  •  Online patient recruitment and its impact on patient relationship management
  •  Pipeline Insight - Non-insulin antidiabetics Incretin mimetics leaders in a diverse pipeline
  •  Pricing and Reimbursement - Seven Major Markets Update
  •  Stakeholder Opinions: Percutaneous Coronary Intervention - Adverse events with drug-eluting stents demand a new safety standard
  •  Commercial Insight: CNS Market Overview - Commercial dynamics and outlook of the neurology, pain and psychiatry market sectors
  •  Commercial and Pipeline Insight: HRT for Menopausal Symptoms – A new class restores an old market
  •  Pipeline Insight: Nosocomial Vaccines - Minefield or Goldmine?
  •  Pipeline Insight: Non-Small Cell Lung Cancer - Pipeline set to offer only modest improvements
  •  Stakeholder Opinions: Heart Failure - When drugs do not work
  •  Pipeline Insight: Breast Cancer - Recent approvals increase pressure on pipeline candidates
  •  Commercial and Pipeline Insight: ADHD - Immature adult market continues to offer greatest commercial potential
  •  Stakeholder Opinions: Portable Inhaler Devices - Key tools to differentiate brands and survive generic pressure
  •  Stakeholder Opinions: Sepsis - The Critical Care Community Gains Critical Mass
  •  Commercial and Pipeline Insight: Opioids - Short acting and anti-abuse technologies set to fragment and grow the market
  •  Pipeline and Commercial Insight: Alzheimer's Disease - Scenario forecasts reveal vast market potential
  •  Stakeholder Opinions: Biologics in Infectious Diseases Well defined target populations are key to commercial success
  •  Pharmaceutical Supply chain strategies: Reassessing product distribution to cut costs and improve supply chain management
  •  Stakeholder Opinions: Systemic Lupus Erythematosus - Market set to enter era of biologic therapies
  •  The Pharmaceutical Industry 2008: Current and Future Trends and Strategic Issues Shaping Pharma
  •  Bone Metastases - Impending patent expiries may help make or break newer agents
  •  Emerging pharmaceutical markets Argentina and Mexico
  •  OTC Pharmaceuticals: Global Industry Guide
  •  Pharmaceuticals: Global Industry Guide 2008
  •  Non-Hodgkin's Lymphoma - Is there room to emulate Rituxan's success?
  •  Prostate Cancer - Hormone-refractory patients still waiting for treatment breakthroughs
  •  Bausch and Lomb's Contact Lens Solution Withdrawal - ReNu MultiPlus likely to struggle in attempt to regain market share
  •  eHealthInsight Series Reaching Doctors and Patients Through New Digital Media
  •  Emerging markets series Benchmarking key countries Brazil, Russia, India, China and Turkey
  •  Commercial Insight Infectious Diseases Overview
  •  Acute Coronary Syndromes Fresh look at ACS in Europe, what is the real picture?
  •  Stakeholder Insight Diabetes
  •  Urinary Incontinence Lifecycle management strategies retain midterm market growth
  •  Commercial Insight Autoimmune Overview Market continues to prosper
  •  Generics Series Key trends and events in the 7 major markets
  •  AntiCounterfeiting Strategies Combating Fake Pharmaceuticals
  •  Stakeholder Opinions Hepatitis C Smallmolecule antivirals pave the way for triple therapy
  •  Stakeholder Opinions Myelodysplastic Syndromes First approvals spur some interest in a niche market
  •  Stakeholder Opinions NonHodgkin's Lymphoma Is there room to emulate Rituxan's success?
  •  Stakeholder Opinions Multiple Myeloma Exploring new targets for multiple drug therapy
  •  Stakeholder Opinions Endometriosis Scientific clarity will unlock market potential
  •  The Pharmaceutical Company Outlook to 2012 Strategic Analysis of the Sales Outlook for Big Pharma, Mid Pharma, Japan Pharma and Biotech
  •  Pipeline perspectives Peripheral artery disease Poor disease awareness hinders new agents
  • La Merie
  •  Oncology Pipeline Database: 1-Year Subscription
  •  Brief Report: Interleukin-17 (IL-17R) and IL-17 Receptor Antagonists
  •  Competitor Analysis: Phosphodiesterase-4 (PDE-4) Inhibitors
  •  Competitor Analysis: PSMA & PSA Targeted Therapy
  •  Competitor Analysis: Selective Estrogen Receptor Modulators
  •  Competitor Analysis: Tissue Growth Factors
  •  Competitor Analysis: Neurotrophic Growth Factors
  •  Competitor Analysis: Growth Factors for Bone, Dental, Cartilage and Tendon Repair
  •  Competitor Analysis: Proteasome Inhibitors
  •  Competitor Analysis: CXCR and CXCL Agonists and Antagonists
  •  Competitor Analysis: TGF-R Agonists and Antagonists
  •  Competitor Analysis: FSH, hCG and LH - Therapeutic Proteins for Assisted Reproductive Technology (ART)
  •  Competitor Analysis: Coagulation Factors
  •  Competitor Analysis: PDGF-R Agonists and Antagonists
  •  Competitor Analysis: EGF-R Agonists and Antagonists
  •  Competitor Analysis: Her2 Receptor Antagonists
  •  Competitor Analysis VEGF and VEGF-R Agonists and Antagonists
  •  Coagulation Factors 2009: Target Pipeline and Corporate Benchmark Analysis
  •  Competitor Analysis: Targeted Therapy of Hepatitis C
  •  Competitor Analysis: CHK and KSP - Eg5 Inhibitors
  •  Competitor Analysis: Bcr-Abl and Src Kinase Inhibitors
  •  Competitor Analysis: PI3K-AKT-mTOR Inhibitors
  •  Competitor Analysis: HDAC Inhibitors
  •  Competitor Analysis: Antibody-Drug Conjugates (ADC)
  •  Competitor Analysis: Immunocytokines
  •  Competitor Analysis: Immunotoxins
  •  Competitor Analysis: MEK Inhibitors
  •  Competitor Analysis: Ras-Raf-MEK-ERK Inhibitors
  •  Competitor Analysis: NGF Agonists & Antagonists
  •  Competitor Analysis: Elastase Inhibitors
  •  Competitor Analysis: Novel Mitotic Kinase Inhibitors
  •  Competitor Analysis: Attention-Deficit Hyperactivity Disorder (ADHD)
  •  Competitor Analysis: Amyotrophic Lateral Sclerosis (ALS)-Lou Gehrig's disease
  •  Competitor Analysis: Sphingosine-1-Phosphate (S1P)
  •  Competitor Analysis: PARP Inhibitors
  •  Competitor Analysis: Hypoxia-Inducible Factor (HIF)
  •  Competitor Analysis: CD3 Antagonists
  •  Competitor Analysis: EpCAM Antagonists
  •  Competitor Analysis: p38 MAPK Inhibitors
  •  Competitor Analysis: Wet Age-Related Macular Degeneration (AMD)
  •  Competitor Analysis: TNF Antagonists & Agonists
  •  Competitor Analysis: PTH Receptor Agonists
  •  Competitor Analysis: C5a-R Antagonists
  •  Competitor Analysis: Protein Kinase C (PKC) Inhibitors
  •  Competitor Analysis: Anti-Infective Peptides
  •  Competitor Analysis: CD20 Antibodies
  •  Competitor Analysis: Janus Kinase (JAK) Inhibitors
  •  Enzyme Replacement & Enhancement Therapies (ERT)
  •  Competitor Analysis: Dipeptidyl peptidase IV (DPP-IV) Inhibitors
  •  Competitor Analysis: Sodium-dependent glucose (co-) transporter (SGLT) Inhibitors
  •  Competitor Analysis: Cannabinoid CB1 receptor antagonists
  •  Diabetes Drug Pipeline
  •  Competitor Analysis: Interferon
  •  Brief Report: Death Receptors TRAIL-R1-2
  •  Brief Report: GM-CSF Antibodies
  •  Brief Report: Syk Kinase Inhibitors
  •  Brief Report: Interleukin-13 (IL-13) Antibodies
  •  Brief Report: Interleukin-12 (IL-12) and IL-23 Antagonists
  •  Brief Report: CD40 and CD40L (CD154) Agonists and Antagonists
  •  Competitor Analysis: Anti-Obesity Biologics
  •  Competitor Analysis: Antithrombotics
  •  Competitor Analysis: Aurora Kinase Inhibitors
  •  Competitor Analysis: c-MET/HGF Inhibitors
  •  Competitor Analysis: Dipeptidyl Peptidase IV (DPP-IV) Inhibitors
  •  Competitor Analysis: Emerging Diabetes Drugs
  •  Competitor Analysis: G-CSF & GM-CSF
  •  Competitor Analysis: GLP-1 Receptor Agonists
  •  Competitor Analysis: Heat shock protein 90 (Hsp90) Inhibitors
  •  Competitor Analysis: Human Growth Hormone (hGH)
  •  Competitor Analysis: IGF-1R Antagonists
  •  Competitor Analysis: PPAR Agonists
  •  Competitor Analysis: Thrombopoiesis-Stimulating Agents (TPO)
  •  Competitor Analysis: Toll-Like Receptor (TLR) Agonists & Antagonists
  •  Competitor Analysis: Systemic Lupus Erythematosus (SLE)
  •  Competitor Analysis: Adenosine Receptor Agonists and Antagonists
  •  Competitor Analysis: Antihypertensives
  •  Competitor Analysis: Integrin Antagonists
  •  Competitor Analysis: Cardiovascular Peptides
  •  Competitor Analysis: Alzheimer’s Disease Antibodies
  •  Competitor Analysis: Antiviral Antibodies
  •  Competitor Analysis: HDL Raising Therapies
  •  R&D Pipeline News
  • Arrowhead Publishers
  •  Drug Delivery Technologies Current Market Dynamics, Future Market Opportunities and Lifecycle Strategies
  •  Cancer Therapeutics Market Insight and R&D Pipeline Analysis
  •  Evidence-Based Medicine Current Use and Future Impact on Global Clinical and Reimbursement Practices
  •  Indian Generics 2008-2012 The Growing Threat to Westernised Markets
  •  The Global Pain Therapeutics Market, 3rd Edition Market Analysis, R&D Pipelines and Competitive Landscape
  •  The Global Antibacterials Market R&D Pipelines Market Analysis and Competitive Landscape
  •  The Global Antivirals Market R&D Pipelines, Market Analysis and Competitive Landscape
  •  A Global Analytical Guide and Comparative Analysis of International Destinations with Location Attractiveness Index
  •  Innovations and Trends in Clinical Trials Microdosing (Phase 0 Trials) Adaptive Trials Phase IV Trials and the Role of Information Technology
  •  The Global Market and Future Outlook for Neurodegenerative Disorder Therapies 2007
  •  Monoclonal Antibodies 2007
  • Biotechnology Information Institute
  •  Biopharmaceutical Expression Systems and Genetic Engineering Technologies
  •  Advances in Biopharmaceutical Technology in India
  •  Directory of Top 60 Biopharmaceutical Manufacturers in China
  •  Directory of Top 60 Biopharmaceutical Manufacturers in India
  •  Biopharmaceutical Products in the U.S. and European Markets, Online Database Edition
  •  Advances in Large Scale BioManufacturing and Scale-Up Production, 2nd Edition
  •  6th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production
  •  Advances in Biopharmaceutical Technology in China
  • Medtech Ventures
  •  Aneurysm Flow Modulating Device Market

    Current Status and Strategic Opportunities


  •  Endovascular Aneurysm Repair Device Market Paradigm Shift & Strategic Opportunities
  •  Aortic EndoGraft Market Current Situation and Future Outlook
  •  Endovascular Cerebral Aneurysm Repair Market Current Situation & Future Outlook
  •  Drug Eluting Coronary Stents Market - Current Situation & Future Outlook
  • TriMark Publications
  •  Molecular Diagnostics in Cancer Testing
  •  Disposable Syringe Markets
  •  Infectious Diseases Drugs Markets
  •  Global Beverages Report
  •  Therapeutic Monoclonal Antibodies Markets
  •  Pharmacogenomics for Clinical Use and in Drug Development
  •  Diabetes, Metabolic Syndrome and Cardiovascular Disease
  •  Companion Biomarkers in Drug Development
  •  Sleep Disorders: Insomnia, Sleep Apnea, Restless Leg Syndrome, Bruxism, Narcolepsy and Sleepwalking
  •  Disposable Medical Supplies Markets
  •  Bioinformatics Markets
  •  Mammography World Markets
  •  High-Growth Diagnostic Testing Markets
  •  Point of Care Diagnostic Testing Sector Trends
  •  Cell-Based Assays for Drug Discovery
  •  Global Medical Tourism
  •  Patient Monitoring Markets
  •  Picture Archiving and Communications Systems (PACS)
  •  Microarray Markets
  •  Medical Nanotechnology Markets
  •  Women's Health: Diagnostic Testing
  •  Microscopy Markets
  •  Indian Pharmaceutical Industry
  •  DNA Sequencing and PCR Markets
  •  Cytology and HPV Testing World Markets
  •  Genomics World Markets
  •  Cancer Therapeutics Markets
  •  Companion Diagnostics in Personalized Medicine and Cancer Therapy
  •  Biomarker Technology Platforms for Cancer Diagnoses and Therapies
  •  Cancer Cell Therapy Markets
  •  Home Medical Testing Devices
  •  Ultrasound Markets
  •  Animal Health Products Antibacterials Markets
  •  Positron Emission Tomography Markets
  •  Personalized Medicine
  •  Veterinary Health Markets
  •  Cell Therapy Markets
  •  Gene Expression Reagents Markets
  •  Clinical Laboratory Testing Volume 2 Business Strategies
  •  Clinical Laboratory Testing Volume 1 Reagents and Instruments
  •  Hematology Analyzer Instrumentation and Reagent Markets
  •  Stem Cell Markets
  •  RNA Interference Markets
  •  Nuclear Cardiology Markets
  •  Clinical Immunoanalyzer Markets
  •  Avian Influenza Report
  •  Blood Glucose Testing and Diabetes Management Report
  •  Clinical Chemistry Analyzers
  •  Nutraceuticals and Dietary Supplements Markets Report
  •  Medical Imaging Markets
  •  Disposable Syringes Markets
  •  Cardiac Marker Diagnostic Testing Markets
  •  Cancer Diagnostic Testing World Markets
  •  Molecular Diagnostics Markets
  •  Point Of Care Diagnostic Testing World Markets
  •  Over The Counter Diagnostic Product World Markets
  • CuttingEdgeInfo Reports
  •  Oncology Market Forecast to 2015 (TA225)
  •  Diabetes Market Forecast to 2015 (TA224)
  •  Pharmaceutical Mergers and Acquisitions (PH133)
  •  Pharmaceutical Speaker Programs (PH134) Measuring ROI and Communicating Value
  •  Strategic Clinical Sourcing (PH125)) Managing Costs and CROs
  •  Designing Patient Communications Programs (PH131) Education, Adherence, and Disease Management
  •  Securing Market Access (PH129) Reimbursement, Payer Relationships and Healthcare Reform
  •  Autoimmune Market Forecast to 2014 (TA223)
  •  Managing Clinical Investigator Compensation (PH126)


  •  Reinventing Pharmaceutical Sales Forces (PH127)
  •  Clinical Outsourcing Strategy

    Selecting Partners and Managing Relationships (PH125)
  •  The Toolkit for Diabetes MSL Programs (PH130)
  •  Key Opinion Leaders

    Relationship Management and Segmentation Data (PH122)
  •  Thought Leader Fair-Market Value Compensation Benchmarks and Procedures (PH121)
  •  Neurodegenerative Market Forecast to 2013 (TA222)
  •  Evolving Medical Information Call Centers through Performance Measurement and Process Improvement (PH124)
  •  Oncology Roadmap: Brand Spending Benchmarks and Market Forecast to 2013 (TA220)
  •  Driving Successful Pharma Brands: Case Studies of Real Product Launches (PH123)
  •  Improve Market Research Impact (PH120)
  •  Diabetes Market Forecast to 2013 (TA221)
  •  Outcomes-Based Pharmaceutical Pricing (PH116)
  •  Pharmaceutical Alliance Management (PH119)
  •  Streamlining Clinical Trials (PH117)
  •  Oncology Market Forecast to 2013 (TA220)
  •  The Evolving Global Meeting Management Strategy (PH111)
  •  Business Development: Accelerating the Deal (PH118)
  •  Pharmaceutical Competitive Intelligence: Expanding the Role and Reach of CI (PH110)
  •  The Changing MSL Role: Proving Value Through Performance Measurement (PH115)
  •  Monitoring and Ensuring Pharmaceutical Compliance (PH113)
  •  Medical Affairs: Delivering Strategic Value (PH112)
  •  Investigator-Initiated Trials: Building Superior IIT Capabilities (PH114)
  •  A Guidebook to Pharma Brand Optimization: Lifecycle Management Strategy (PH108)
  • Select Bioscience Reports
  •  Stem Cells in Regenerative Medicine 2008 Market Report
  •  Cancer Personalized Medicine 2008
  •  Multiplexed Diagnostics 2008 Market Report
  •  Epigenetics and MicroRNA Diagnostics Therapeutics 2008
  • Jain PharmaBiotech Reports
  •  DNA Sequencing - technologies,markets and companies
  •  Antiviral Therapeutics - technologies, markets and companies
  •  Cytogenetics - technologies, markets and companies
  •  Biomarkers - technologies, markets and companies
  •  Cardiovascular Drug Delivery - technologies, markets and companies
  •  Molecular Diagnostics - Technologies, Markets and Companies
  •  Cell Therapy - Technologies, Markets and Companies
  •  Proteomics - Technologies, Markets and Companies
  •  Neuroprotection - Drugs, Markets and Companies
  •  Transdermal Drug Delivery - Technologies, Markets, and Companies
  •  Animal Biotechnology - Technologies, Markets and Companies
  •  Pain Therapeutics - Drugs, Markets and Companies
  •  Personalized Medicine - scientific and commercial aspects
  •  Nitric Oxide - Therapeutics, Markets and Companies
  •  Alzheimer disease - new drugs, markets and companies
  •  Drug Delivery in Cancer - technologies, markets and companies
  •  RNAi - technologies, markets and companies
  •  Gene Therapy - technologies, markets and companies
  •  Nanobiotechnologies - applications, markets and companies
  •  Drug Delivery in Central Nervous System Disorders - technologies, markets and companies
  • Advertising on Bioportfolio
  • BioPortfolio Membership
  • Urch Publishing Reports
  •  World Market for Addiction Disorders, 2009-2016
  •  Pharmaceutical Distribution in the US - Current and Future Perspectives
  •  Mergers and Acquisitions in the Pharmaceuticals Sector, 2009
  •  Virtual Pharma The radical route to success
  •  Quality for Biologics
  •  Cancer Market Trends 2008 - 2012
  •  Major Pharmaceutical Markets of the Middle East (2nd Ed)
  •  How to Forecast Generic Pharmaceutical Prices
  •  Manufacturing in the Global Pharmaceuticals Industry Key drivers, company strategies and regulations (3rd Edition)
  •  Pharmaceutical Distribution in Europe The Emergence of Direct-to-Pharmacy Supply
  •  Pharmaceutical Product Approval Trends, 2007
  •  Consolidation in the Generic Pharmaceutical Industry An evolving landscape
  •  Pharmaceutical Market Trends, 2008 - 2012
  •  Cardiovascular Pharmaceutical Market Trends, 2007 to 2010
  •  CNS Market Trends 2007 to 2010
  •  Handbook of Pharmaceutical Additives
  • Access China
  •  Latest Chinese Regulations for Imported Drug Registration
  •  China's Guidebook for Pharmaceutical Patent Protection
  •  China Pharmaceutical Guidebook Series (4)
  •  China Pharmaceutical Guidebook Series (3)
  •  China Pharmaceutical Guidebook Series(2)
  •  China Pharmaceutical Guidebook Series (1)
  •  How to Merge the Chinese Enterprises
  •  Chinese Pharmaceutical Industry
  • Specials
  • Datamonitor Reports
  •  Stakeholder Opinions: Back Pain - Gain competitive edge by targeting subpopulations
  •  Biogen Idec Inc.: PharmaVitae Profile
  •  Pharmaceuticals: Global Industry Almanac
  •  OTC Pharmaceuticals: Global Industry Almanac
  •  Pipeline Insight: Benign Prostatic Hyperplasia - Novel therapeutics and reformulations will drive market growth
  •  Pipeline Insight: Hematological Malignancies Companies target niche indications to facilitate market entry
  •  Stakeholder Opinions: Renal Anemia Early diagnosis and management of anemia: reducing costs and improving the outcomes in chronic kidney disease
  •  Stakeholder Opinions: Urinary Tract Infections Growing resistance rates bring opportunities for both new and old drugs
  •  Stakeholder Opinions: Hematopoietic Stem Cell Transplantation - In need of further research and development
  •  Pharmaceuticals: United States Industry Guide
  •  Pharmaceuticals: United Kingdom Industry Guide
  •  Pharmaceuticals: Spain Industry Guide
  •  Pharmaceuticals: Netherlands Industry Guide
  •  Pharmaceuticals: Japan Industry Guide
  •  Pharmaceuticals: Italy Industry Guide
  •  Pharmaceuticals: Global Industry Guide
  •  Pharmaceuticals: Germany Industry Guide
  •  Pharmaceuticals: France Industry Guide
  •  Pharmaceuticals: Europe Industry Guide
  •  Pharmaceuticals: China Industry Guide
  •  Pharmaceuticals: Canada Industry Guide
  •  Pharmaceuticals: Belgium Industry Guide
  •  Pharmaceuticals: Asia-Pacific Industry Guide
  •  Pharmaceuticals - Top 5 Emerging Markets Industry Guide
  •  Stakeholder Opinions: Gastric Cancer - Targeted therapies compete for first-to-market status
  •  Stakeholder Opinions: Vaccine administration technologies - Beyond needles
  •  The Internet is for Healthcare
  •  Healthcare: Global Industry Guide
  •  Nicotine Dependence Market Forecast
  •  Pharmaceuticals - North America (NAFTA) Industry Guide
  •  Pharmaceuticals - BRIC (Brazil, Russia, India, China) Industry Guide
  •  Pricing and Reimbursement in The United Arab Emirates
  •  Stakeholder Opinions: Commercial strategies in cardiovascular and metabolic diseases successful market positioning at company and brand level becomes paramount
  •  Future Pharmaceutical Industry Trends: Long-term opportunities tempered by short-term challenges
  •  Stakeholder Opinions: Celiac Disease - Licensing opportunities exist in untapped market
  •  Otsuka Pharmaceutical Group: PharmaVitae Profile
  •  Dainippon Sumitomo Pharma Co. Ltd: PharmaVitae Profile
  •  Mitsubishi Tanabe Pharma Corporation: PharmaVitae Profile
  •  Merck KGaA: PharmaVitae Profile
  •  Chugai Pharmaceutical Co. Ltd: PharmaVitae Profile
  •  King Pharmaceuticals Inc.: PharmaVitae Profile
  •  UCB S.A.: PharmaVitae Profile
  •  Bayer Schering Pharma AG: PharmaVitae Profile
  •  Wyeth: PharmaVitae Profile
  •  Merck & Co. Inc: PharmaVitae Profile
  •  F. Hoffmann-La Roche Ltd.: PharmaVitae Profile
  •  GlaxoSmithKline plc: PharmaVitae Profile
  •  Sepracor Inc.: PharmaVitae Profile
  •  Menarini: PharmaVitae Profile
  •  Solvay S.A.: PharmaVitae Profile
  •  Stakeholder Opinions: Tuberculosis - Development pipeline shows signs of life
  •  Opioids Market Forecast
  •  Stakeholder Opinions: Pulmonary Arterial Hypertension clinical community builds order from chaos
  •  Forecast Insight: Opioids - Saturation limits the commercial potential of individual brands
  •  Genzyme Corporation: PharmaVitae Profile
  •  Genentech Inc.: PharmaVitae Profile
  •  Amgen Inc.: PharmaVitae Profile
  •  Celgene Corporation: PharmaVitae Profile
  •  Shire plc: PharmaVitae Profile
  •  Alcon Inc.: PharmaVitae Profile
  •  Les Laboratoires Servier: PharmaVitae Profile
  •  Boehringer Ingelheim GmbH: PharmaVitae Profile
  •  Schering-Plough Corporation: PharmaVitae Profile
  •  Abbott Laboratories: PharmaVitae Profile
  •  Johnson & Johnson: PharmaVitae Profile
  •  Pfizer Inc.: PharmaVitae Profile
  •  Generic Benchmarking: Brand Erosion at Patent Expiry
  •  Stakeholder Opinions: Pancreatic Cancer - Gemzar dominance will continue among high levels of persistent unmet needs
  •  Stakeholder Insight: Psoriasis - Biologics are yet to make topical treatments obsolete
  •  Stakeholder Opinions: Physician perception of biologics in autoimmune disease - Targeted detailing is the key to success
  •  Stakeholder Opinions: Cystic Fibrosis - A pipeline full of hope
  •  Bristol-Myers Squibb Co.: PharmaVitae Profile
  •  Eli Lilly & Co.: PharmaVitae Profile
  •  AstraZeneca plc: PharmaVitae Profile
  •  Daiichi Sankyo Co., Ltd: PharmaVitae Profile
  •  Astellas Pharma Inc.: PharmaVitae Profile
  •  Eisai Co. Ltd: PharmaVitae Profile
  •  Takeda Pharmaceutical Co. Ltd: PharmaVitae Profile
  •  Commercial Insight: Cardiovascular and metabolic market overview Diabetes to the fore as generics hit primary care markets
  •  Stakeholder Opinions: Cancer Cachexia - Higher profile needed to unlock market potential of neglected syndrome
  •  Pricing and Reimbursement in Key Asia Pacific Markets
  •  Antithrombotics Market Forecast
  •  CV & Diabetes Market Forecast
  •  Commercial Insight: Community Antibacterials - Pipelines wither as generic tidal wave takes its toll
  •  Hepatitis C Market Forecast
  •  Orthopedics: Global Industry Guide
  •  Generics: Global Industry Guide
  •  Pharmaceutical Company Outlook to 2013
  •  Business Trends: Understanding Your Healthcare Technology Customer (Customer Focus)
  •  Finding a Place for Real Time Location Systems in Healthcare (Strategic Focus)
  •  Divestment Strategies: Pharma is divesting in order to grow
  •  Stakeholder Insight: Acute Coronary Syndromes ACS in Europe, what is the best practice?
  •  Stakeholder Opinions: Sarcomas
  •  Forecast Insight: Antithrombotics - Market growth dependent on new agents
  •  Forecast Insight: Epilepsy - Future market upgrade following new drug launches
  •  Biotech Financing in the Credit Crisis: Strategies for a radically altered landscape
  •  Stakeholder Opinions: Type 2 Diabetes in the UAE & Saudi Arabia Growth opportunities in fragmented markets
  •  Forecast Insight: Depression - Generic induced brand erosion leads to market decline
  •  Stakeholder Opinions: Narcolepsy - Entry-point to a lucrative fatigue-associated market
  •  Commercial Insight: Solid organ transplantation - The impact of new biologics, generics and reformulations
  •  Pipeline and Commercial Insight: Hepatitis C - High unmet need drives rapid innovation
  •  Forecast Insight: Migraine - Generic incursion inhibits market growth
  •  Stakeholder Insight: Infertility - Undifferentiated drugs force need to strengthen prescriber and payer relationship
  •  2009 Trends to Watch: Healthcare Technology
  •  Generics Series: Generics Trends in the Seven Major Markets and Beyond
  •  eHealthInsight Series: The Changing Direct-to-Consumer Advertising Landscape
  •  Stakeholder Insight: Chronic Leukemias - Is there room left for improvement
  •  Stakeholder Opinions: Restless Legs Syndrome - Novel drugs to prosper as lifecycle management strategies fail
  •  Pipeline and Commercial Insight: Anxiety Disorders - Viable indication for antipsychotics companies
  •  Molecular Diagnostics: a primer on an emerging sector
  •  Stakeholder Insight: Systemic Lupus Erythematosus Imprecise segmentation complicates treatment algorithms
  •  Stakeholder Opinions: Bladder Cancer - New drugs needed to challenge ineffective 20-year old drugs
  •  Pipeline Insight: Orphan Diseases in Neurology - Part III: Myasthenia Gravis
  •  Stakeholder Opinions: Diabetic Renal Disease
  •  RNA therapy: the next big thing after monoclonal antibodies
  •  Forecast Insight: Antidiabetics - Switching to new molecule antidiabetics drives market growth
  •  Commercial Insight: Pain Market Overview - Non-traditional analgesics and opioid reformulations to sustain sector growth
  •  Pipeline Insight: Non-insulin antidiabetics Incretin mimetics leaders in a diverse pipeline
  •  M&A trends in Pharma
  •  Strategic Perspectives: Antidyslipidemics Current market is not conducive for growth
  •  Building a Network of Networks to Achieve Interoperability in Healthcare (Strategic Focus)
  •  Pipeline and Commercial Insight: Schizophrenia - Second generation depots protect market value
  •  Emerging Markets Series: The Pharmaceutical Market of South Korea
  •  Stakeholder Insight: Osteoporosis - Generic alendronate further establishes oral bisphosphonates as gold standard
  •  Forecast Model: Antidyslipidemics - Genericization and negative trial data drive market shrinkage
  •  Sales Force Effectiveness
  •  Trends in Pharmaceutical Portfolio Management - Strategies to maintain profitability despite adversity
  •  Trends in Clinical Trials: Strategies to enhance clinical trial design
  •  Stakeholder Opinions: Vaccine adjuvants - uncertainties rule
  •  Forecast Insight: Parkinson's Disease - Market upgrade following evidence of disease slowing with Azilect
  •  Forecast Insight: Dyslipidemia - Genericization and negative trial data drive market shrinking
  •  Commercial Insight: Antihormonal Therapy Cancer Brands - Careful lifecycle management needed to preserve brand dominance
  •  Forecast Insight: Multiple Sclerosis - Tysabri to prevail despite safety setbacks
  •  Forecast Insight: Insomnia Orexin and serotonin receptor modulators to innovate market
  •  Commercial Insight: HIV - The battle for market share is getting fiercer
  •  Biosimilars Series: Stakeholder Analysis
  •  UK Healthcare Cash Plans 2008
  •  Forecast Insight: Antihypertensives Key patent expiries prevent market growth
  •  Commercial Insight: Cytotoxic Therapy Cancer Brands - Looming patent expiries limit market growth
  •  Commercial Insight: Targeted Therapy Cancer Brands - High growth market will see eight new blockbusters by 2017
  •  Generic Series: Optimizing Brand Lifecycle Management Winning Strategies to Maximize Revenue in the Face of Growing Generic Competition
  •  Pipeline Insight: Insulin antidiabetics - Return to injections alternative delivery methods fall by the wayside
  •  Stakeholder Opinions: Diagnostics in Neurology - Predictive biomarkers expand drug revenues
  •  Stakeholder Opinions: Novel Therapeutic Approaches in Cardiovascular Medicine - Lack of market prospects for biologics expose an opportunity for cell and gene therapies
  •  Commercial and Pipeline Insight: Vaccines for Adults and the Elderly - New blockbuster opportunities ahead
  •  Commercial and Pipeline Insight: Fibromyalgia - Approvals legitimize condition and expose underserved patient population
  •  Stakeholder Insight: Asthma - Over-prescribing is common in intermittent and mild forms of asthma
  •  Global Healthcare Technology Spending Forecast Through 2013 (Interactive Model)
  •  Rx-to-OTC Strategies: Maximizing the Commercial Potential of an Rx-to-OTC Switch
  •  Stakeholder Opinions: Non-hormonal Treatments for Menopausal Symptoms - Market open to takers as tepid pipeline fails to meet demand
  •  Pipeline and Commercial Insight: Neuropathic Pain - UCB's Vimpat set to compete with major players
  •  Pricing & Reimbursement - Seven Major Markets Update
  •  Online patient recruitment and its impact on patient relationship management
  •  Pipeline Insight: Acute Stroke: Commercial risk offsets high unmet need
  •  Forecast Insight: Osteoarthritis - The COX-2 pipeline collapses
  •  Clinical Decision Support in Healthcare - One step closer to the Omniscient Clinician (Strategic Focus)
  •  Drug Repositioning Strategies - Serendipity by design
  •  Stakeholder Opinions: Percutaneous Coronary Intervention - Adverse events with drug-eluting stents demand a new safety standard
  •  Stakeholder Opinions: Heart Failure - When drugs do not work
  •  Pipeline Insight: Nosocomial Vaccines - Minefield or Goldmine
  •  Commercial and Pipeline Insight: HRT for Menopausal Symptoms – A new class restores an old market
  •  Pipeline Insight: Non-Small Cell Lung Cancer - Pipeline set to offer only modest improvements
  •  Commercial and Pipeline Insight: ADHD - Immature adult market continues to offer greatest commercial potential
  •  Stakeholder Opinions: Portable Inhaler Devices - Key tools to differentiate brands and survive generic pressure
  •  Claims Processing for Healthcare Payers (Market Model)
  •  Improving Efficiencies through the Development of Claims Processing in Healthcare (Strategic Focus)
  •  Stakeholder Opinions: Sepsis - The Critical Care Community Gains Critical Mass
  •  Commercial and Pipeline Insight: Opioids - Short acting and anti-abuse technologies set to fragment and grow the market
  •  Pipeline and Commercial Insight: Alzheimer's Disease - Scenario forecasts reveal vast market potential
  •  Stakeholder Opinions: Biologics in Infectious Diseases Well defined target populations are key to commercial success
  •  Pharmaceutical Supply chain strategies: Reassessing product distribution to cut costs and improve supply chain management
  •  Stakeholder Opinions: Systemic Lupus Erythematosus - Market set to enter era of biologic therapies
  •  The Pharmaceutical Industry 2008: Current and Future Trends and Strategic Issues Shaping Pharma
  •  Stakeholder Opinions: Bone Metastases - Impending patent expiries may help make or break newer agents
  •  Emerging pharmaceutical markets Argentina and Mexico
  •  2008 Trends to Watch: Healthcare Technology
  •  eHealthInsight Series: Reaching Doctors and Patients Through New Digital Media
  •  Business Trends - Healthcare Technology (Customer Focus)
  •  Healthcare Technology Opportunities in the Electronic Health Record Market (Review Report)
  •  Pipeline Insight: Biologic Targeted Cancer Therapies - Next generation jostles for market position
  •  Benchmarking the Pharmaceutical Market by Drug Delivery to 2014
  •  Pharmaceutical Company Outlook to 2014
  •  Stakeholder Insight: Cancer Pain - Physician survey highlights inadequacies in education and treatment
  •  Generics Series: Generics Overview in the Seven Major Markets
  •  Commercial Insight: Antibacterials - Opportunities in the hospital sector contrast with the lack of innovation in community market
  •  Commercial Insight: Antithrombotics - Crossroads at the patent cliff
  •  Forecast Insight: Dyslipidemia - While the market collapses, a well designed clinical trial program pays dividends for Crestor
  •  Stakeholder Insight: Non-Hodgkin's Lymphomas Diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL)
  •  2009 Pharmaceutical M&A Overview
  •  Stakeholder Opinions: Therapeutic Vaccines - A far-off promise of greatness
  •  Stakeholder Insight: Hepatitis B & C in Asia - China, South Korea, Taiwan and Turkey
  •  Stakeholder Opinions: Biomarkers in Rheumatology - Awaiting the next step towards personalized medicine
  •  Pipeline Insight: Multiple Sclerosis - Risk-benefit ratio under the spotlight for potent pipeline drugs
  •  Pipeline Insight: Endometriosis - New therapies near market while more innovative targets still needed
  •  Big Pharma Mega-Mergers 1995-2014
  •  Stakeholder Opinions: Gene Therapy - Gene therapy to deliver after 20 years of clinical development
  •  Forecast Insight: Neuropathic Pain - Brighter future for pipeline drugs while current brands downgraded
  •  Stakeholder Insight: Osteoarthritis - Drug development lags behind rising osteoarthritis population
  •  Big Pharma Performance Before, During and Beyond the Global Recession
  •  Mapping the Healthcare Landscape Bringing pharmaceuticals into focus
  • Business Insights Reports
  •  The Top Ten Specialty Pharmaceutical Companies: Positioning, performance and SWOT analyses
  •  The Promotional Landscape in US and Europe: Benchmarking promotional ROI and optimizing detailing and journal spend
  •  The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
  •  Biotech M&A Strategies: Deal assessments, trends and future prospects
  •  Successful Pharmabiotech Alliance Strategies: Driving synergies, avoiding failure and managing relationships
  •  The CNS Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
  •  The Future of RNAi Therapeutics: Drug Pipelines and Prospects
  •  Innovative Strategies and Models for R&D Success: The evolving networked pharma company
  •  Innovations and Pipelines for Respiratory Disorders: Niche markets, new products and future developments
  •  The Anti-Infectives Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
  •  The Top 10 Generic Pharmaceutical Companies: Positioning, performance and SWOT analyses
  •  Valuing Pharmaceutical Innovation: Pricing and reimbursement for innovative therapies
  •  Obesity Drug Markets in the US and EU: Analysis of product pipelines and the competitive environment
  •  Innovations in The Management of Diabetes: Next generation treatments and market dynamics
  •  Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
  •  Contract Manufacturing Strategies: Market developments, technology transfer and key success factors
  •  The Emerging Role of Postmarketing Clinical Research: Regulatory issues, strategic drivers and overall trends
  •  Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets
  •  The Convergence of Biomarkers and Diagnostics: Therapy area analyses, key products and future trends
  •  Drug Approval Trends at the FDA and EMEA: Process improvements, heightened scrutiny and industry response
  •  The Fastest Growing Biotechnology Companies: Growth strategies, comparative analyses and company profiles
  •  Impact of Pharmacogenomics on Public Healthcare Policy: Educating patients, payors and healthcare providers
  •  The Future of Targeted Therapeutics: Key technologies, new therapy area applications and leading players
  •  The Cardiovascular Disorders Market Outlook to 2012
  •  Launching Combination Products: Brand extension and franchise development strategies
  •  Innovations in Bioinformatics: Emerging tools for drug discovery and development
  •  The Cancer Market Outlook to 2012
  •  Nanotechnology: Revolutionizing R&D to develop smarter therapeutics and diagnostics
  •  Early Stage Drug Safety Strategies and Risk Management: Maximizing opportunities towards achieving clinical success
  •  The Top 10 Biosimilar Players: Positioning, performance and SWOT analyses
  •  Key Players in Pharmaceutical Contract Manufacturing: Market developments, outsourcing hotspots and growth strategies
  •  The Scandinavian Pharmaceutical Market Outlook to 2013: Policy environment, market structure, pipeline analysis, growth opportunities
  •  The Canadian Pharmaceutical Market Outlook to 2013: Policy environment, market structure, pipeline analysis, growth opportunities
  •  The Asian Cardiovascular Market Outlook to 2014: Regional and therapeutic analysis, pipeline impact and growth opportunities
  •  The Future of Biobanks: Regulation, ethics, investment and the humanization of drug discovery
  •  The Top 10 Contract Research Organizations: Positioning, performance and SWOT analyses
  •  The Autoimmune Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
  •  The Top Ten Global In-Vitro Diagnostics Companies: Positioning, performance and SWOT analyses
  •  Key Trends in Offshoring Pharmaceutical R&D: Company strategies, emerging markets and impact on ROI
  •  Evolving Trends in Biopharmaceutical Licensing: Deal assessments, drivers and resistors
  •  Technology Transfer Strategies: Maximizing the returns from new technologies
  •  Negotiating the Emerging Biosimilars Landscape: Key developments in the regulatory environment
  •  The Cardiovascular Market Outlook to 2013: Competitive landscape, global market analysis and pipeline analysis
  •  Delivery Mechanisms for Large Molecule Drugs: Successes and failures of leading technologies and key drivers for market success
  •  Intellectual Property and Outsourcing in China: Minimizing risk whilst maximizing return on investment
  •  The Cancer Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
  •  The Pharmaceutical Market Outlook to 2018: Key threats and opportunities for Big Pharma and its responses to them
  • GlobalData Reports
  •  Japan Interventional Cardiology Devices: Coronary Stents to Drive Growth
  •  Diagnostic Imaging Companies Expand Into IVD Market – Driving Growth through Continuum of Care
  •  The Medical Equipment Regulatory Scenario in BRIC Countries
  •  Bristol Myers Squibb Sells Convatec A Strategic Shift In Focus to Biopharmaceuticals
  •  Driven by Synergies in the Pharmaceutical and Ophthalmic Devices Portfolio- Novartis to Acquire Alcon’s Majority Share from Nestle
  •  Rapidly Growing China Medical Equipment Market – An inevitable Opportunity for the Global Manufacturers
  •  Xience V – Leapfrogging To Lead DES Market In The US
  •  EnRhythm MRI SureScan – Medtronic Keeps Pace With MRI Needs
  •  The FDA Seeks More Power for Better Regulation of Medical and Healthcare Products
  •  Medtronic Acquires Kyphon – A Move to Raise Growth Momentum by Inorganic Growth and Creating Synergies in the Spinal Surgery Portfolio
  •  Medtronic Expands Its Presence In The Fast Growing Chinese Market
  •  Roche On The Path To Inorganic Growth – Acquires Ventana To Enhance Diagnostic Capabilities
  •  New Ruling To Provide Immunity For Medical Equipment Manufacturers
  •  Bioabsorbable Stents - Poised to Drive Growth Momentum in the Coronary Stent Market
  •  Vertebroplasty Continues to Lead VCF Surgery Market
  •  Varicose Veins Market Outlook
  •  Tumor Ablation Market Outlook
  •  Hip Resurfacing and Large Metal Head Market
  •  Thrombectomy Market Outlook
  •  Electrophysiology Market Outlook
  •  Embolotherapy Market Outlook
  •  Partial Knee Replacement-A ConforMIS Approach
  •  Cordis Losing Market Share in Stents, Shifts Focus to Other Lucrative Segments
  •  Wall Street Financial Crisis The Medical Equipment Industry Perspective
  •  BSN Medical is up for grabs “When” is the question.
  •  Medical Equipment M&A Trends - October 2008
  •  Warburg Pincus to Strengthen Stand in Dental and Surgical Market
  •  Advanced Wound Care Market Outlook
  •  Knee Implant Market of the Future – Gender No Bar
  •  FDA in Favor of Off-Label Marketing
  •  Olympus To Acquire Gyrus Group
  •  Reimbursement for Remote Patient Monitoring in the United States- Regulatory Antennae Picking Up Demand Signals
  •  Medical Equipment M&A Trends - November 2008
  •  Mergers & Acquisitions and Financing Trends in Medical Equipment Q3 2008
  •  Atrial Fibrillation Pipeline Product and Technology Analysis Report
  •  Orthopedic Devices Pipeline Product Analysis and Technology Report
  •  Drug Eluting Stent Coatings – New Horizons
  •  Device Approval Trends A Global Perspective
  •  Roche Acquires Genentech – Combined Synergy to Create a Global Leader in Healthcare
  •  Intuitive Surgical and Power Medical Agreement Boosts Minimally Invasive Surgical Offering
  •  Why Robotics (Surgery) has not been Successful in Orthopedics
  •  Radiological Society of North America Annual Meeting 2008 – Post Conference Review
  •  Medical Equipment M&A Trends – December 2008
  •  Abdominal Aortic Aneurysm Pipeline Product and Technology Analysis Report
  •  Hip Resurfacing Pipeline Product and Technology Analysis Report
  •  Transcatheter Valve Replacement Pipeline Product and Technology Analysis Report
  •  Philips to Acquire Meditronics: Betting Big on the Emerging Market Opportunities
  •  Johnson & Johnson to Acquire Mentor Corporation: Expanding Presence in the Aesthetic Devices Market
  •  Medical Equipment Mergers & Acquisitions Trends – January 2009
  •  Aesthetics Devices Pipeline Product and Technology Analysis Report
  •  Neurostimulation Devices Pipeline Product and Technology Analysis Report
  •  Digital Mammography Pipeline Technology and Market Forecasts To 2015
  •  Mergers & Acquisitions and Financing Trends in Medical Equipment Industry Q4 2008
  •  Cell Therapy - A New Lease of Life for the Heart
  •  Combination Products - Evolution of the Medical Equipment Industry
  •  Small Joints - Big Innovations
  •  Key M&A Events in the Spinal Surgery Market in 2008
  •  Abbott Laboratories to Acquire Advanced Medical Optics: Betting Big on the Ophthalmic Devices Market
  •  Insulin Pumps Pipeline Technology And Market Forecasts To 2015
  •  North America Negative Pressure Wound Therapy (NPWT) Market: Strategic Market Analysis and Insight to 2012
  •  Aesthetic Devices Market: The Global M&A Landscape
  •  Personalized Implants –A ConforMIS Approach
  •  SWOT Review of the Diagnostic Imaging Big-Three
  •  SWOT Review of the Key Ophthalmic Device Companies
  •  Medical Equipment Mergers & Acquisitions Trends – February 2009
  •  Transcatheter Cardiovascular Therapeutics 2008 – Post Conference Review
  •  Medtronic to Acquire Ablation Frontiers: A Move to Strengthen Stake in the Atrial Fibrillation Market
  •  Cardiovascular Surgery Pipeline Technology and Market Forecasts To 2015
  •  US Electrophysiology Devices Market: Opportunity Analysis and Market Assessment to 2015
  •  SWOT Review of the Key Orthopedic Device Companies
  •  Global X-Ray Systems Market: Strategic Market Analysis and Insight to 2015
  •  Global Self Monitoring Blood Glucose Market (SMBG): Increasing Adoption to Drive Growth
  •  US Cardiac Rhythm Management Devices Market: Strategic Market Analysis and Insight to 2015
  •  Electrosurgical Devices Pipeline Technology and Market Forecasts to 2015
  •  Mergers & Acquisitions and Financing Trends in Medical Equipment, 2008
  •  United States Medical Equipment Market Analysis & Forecasts to 2015
  •  United States Patient Monitoring Market Analysis & Forecasts to 2015
  •  Japan Patient Monitoring Market Analysis & Forecasts to 2015
  •  Dynamic Stabilization Pipeline Technology and Market Forecasts to 2015
  •  Capsule Endoscopy: Small is Effective
  •  Kyphoplasty: Driving Growth in the Vertebral Compression Fracture Treatment Market in the US
  •  Global Respiratory Devices Market: The Home and Self Care Products to Drive Growth
  •  Knee Replacement Pipeline Technology and Market Forecasts to 2015
  •  Germany Diabetes Care Devices Market Analysis & Forecasts to 2015
  •  United States Ophthalmic Devices Market Analysis & Forecasts to 2015
  •  Medical Equipment Weekly Deals Summaries 01 April 2009
  •  Medical Equipment Weekly Deals Summaries 06 April 2009
  •  Medical Equipment Mergers & Acquisitions Trends – April 2009
  •  Ultrasound Systems Pipeline Technology and Market Forecasts to 2015
  •  Wound Closure Devices Pipeline Technology and Market Forecasts to 2015
  •  American Association of Orthopedic Surgeons (AAOS) 2009: Conference Review and Analysis
  •  Israel Diabetes Care Devices Market Analysis & Forecasts to 2012
  •  Mexico Diabetes Care Devices Market Analysis & Forecasts to 2015
  •  United States Remote Patient Monitoring Market -Favorable Reimbursement Scenario to Drive Growth
  •  Europe Orthopedic Biomaterials Market: Product Penetration to Drive Growth
  •  Europe Electrophysiology Devices Market: Increasing Demand to Drive Growth
  •  India Diabetes Care Devices Market Analysis and Forecasts to 2015
  •  China Diabetes Care Devices Market Analysis & Forecasts to 2015
  •  Atrial Fibrillation Pipeline Technology and Market Forecasts to 2015
  •  Cataract Surgery Pipeline Technology and Market Forecasts to 2015
  •  Germany Patient Monitoring Market Analysis & Forecasts to 2015
  •  India Patient Monitoring Market Analysis & Forecasts to 2015
  •  Australia Patient Monitoring Market Analysis & Forecasts to 2015
  •  Brazil Patient Monitoring Market Analysis & Forecasts to 2015
  •  China Patient Monitoring Market Analysis & Forecasts to 2015
  •  France Patient Monitoring Market Analysis & Forecasts to 2015
  •  United Kingdom Patient Monitoring Market Analysis & Forecasts to 2015
  •  Medical Equipment Weekly Deals Summaries 13 April 2009
  •  Mergers & Acquisitions and Financing Trends in Medical Equipment Q1 2009
  •  Medical Equipment Weekly Deals Summaries 20 April 2009
  •  International Society of Arthroscopy, Knee Surgery & Orthopedic Sports Medicine 2009 – Conference Review And Analysis
  •  The Dawn Of Consolidation In The Spinal Surgery Market: Nuvasive To Acquire Cervitech
  •  Japan Diabetes Care Devices Market Analysis and Forecasts to 2015
  •  Dental Implants Pipeline Technology and Market Forecasts to 2015
  •  Medical Equipment Weekly Deals Summaries 27 April 2009
  •  Medical Device Clinical Trials: Destination India
  •  Stem Cell Research and Tissue Engineering: A Boon for Dental Tissue Regeneration
  •  Dental Aesthetics Pipeline Technology and Market Forecasts to 2015
  •  Europe Coronary Stents Market: Revival of Drug Eluting Stents to Drive Growth
  •  United States Coronary Stents Market: Revival of Drug Eluting Stents to Drive Growth
  •  United States Dental Devices Market Analysis and Forecasts to 2015
  •  South and Central America Patient Monitoring Market Analysis & Forecasts to 2015
  •  Medical Equipment Mergers & Acquisitions Trends – May 2009
  •  Medical Equipment Weekly Deals Summaries 18 May 2009
  •  Symposium on Advanced Wound Care and the Wound Healing Society Meeting 2009 –Conference Review And Analysis
  •  United States Hip Resurfacing Implants Market: Product Penetration to Drive Growth
  •  Global Hip and Knee Implants: Market Penetration to Drive Growth
  •  Germany Dental Devices Market Analysis and Forecasts to 2015
  •  Italy Patient Monitoring Market Analysis & Forecasts to 2015
  •  Spain Patient Monitoring Market Analysis & Forecasts to 2015
  •  Drug Delivery: Heading Towards A Needle Free Future
  •  Liver Assist Devices: Decreasing Liver Transplant Waitlists
  •  Flexible Endoscope Pipeline Technology and Market Forecasts to 2015
  •  Medical Equipment Weekly Deals Summaries 25 May 2009
  •  Medical Equipment Weekly Deals Summaries 01 June 2009
  •  Biliary Stents: Off – Label Use to Drive Growth
  •  The Medical Device Reprocessing Industry: Increasing Hospital Sustainability
  •  Artificial Disc Replacement Pipeline Technology and Market Forecasts to 2015
  •  Advanced Wound Management Pipeline Technology and Market Forecasts to 2015
  •  Japan Wound Care Management Market Analysis and Forecasts to 2015
  •  Medical Equipment Monthly Deals Analysis – October 2009
  •  Germany Diagnostic Imaging Market Analysis and Forecasts to 2015
  •  India Medical Equipment Industry: Defying Global Recession
  •  The US Government’s Financial Support to Push Comparative Effectiveness Research
  •  Chronic Diseases on the Rise: Personal Health Systems to Play a Key Role in Disease Management
  •  Home Healthcare Equipment in the UK: A Market Snapshot
  •  Increasing Incidence of End-Stage Renal Disease Driving the Peritoneal Dialysis Market
  •  Dental Implants Market: Increasing Clinical Familiarity to Drive Growth
  •  Patent Foramen Ovale Closure Market: Clinical Trial Outcomes to Play a Key Role
  •  Intra Vascular Ultrasound (IVUS) Imaging to Play a Key Role in Increasing Clinical Success of Interventional Cardiology
  •  Spain Medical Equipment Market Analysis and Forecasts to 2015
  •  Medical Equipment Industry Deals Analysis – September 2009
  •  Canada Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015
  •  Brazil Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015
  •  Italy Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015
  •  Spain Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015
  •  UK Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015
  •  Insulin Delivery Devices Pipeline Technology and Market Forecasts to 2015
  •  UK Wound Care Management Market Analysis and Forecasts to 2015
  •  Europe Spinal Surgery Devices Market: Increasing Procedures to Drive Growth
  •  Germany Medical Equipment Market Analysis and Forecasts to 2015
  •  Medical Equipment Merger & Acquisition Trends – April 2008
  •  Japan Medical Equipment Market Analysis and Forecasts to 2015
  •  United Kingdom Medical Equipment Market Analysis and Forecasts to 2015
  •  Canada Medical Equipment Market Analysis and Forecasts to 2015
  •  Medical Equipment Merger & Acquisition Trends – May 2008
  •  France Medical Equipment Market Analysis and Forecasts to 2015
  •  Computer Assisted Radiology and Surgery (CARS) 2009 Conference Review and Analysis
  •  Italy Medical Equipment Market Analysis and Forecasts to 2015
  •  US Insulin Delivery Devices: Patient Acceptance Drives Demand
  •  Medical Equipment Merger & Acquisition Trends – June 2008
  •  ev3 to Acquire Chestnut Medical: Favoring Specialization over Diversification
  •  Medical Equipment Merger & Acquisition Trends – July 2008
  •  Medical Equipment Merger & Acquisition Trends – August 2008
  •  Medical Equipment Merger & Acquisition Trends – September 2008
  •  US and European Ultrasound Systems Increasing Demand to Drive Growth
  •  US Magnetic Resonance Imaging (MRI) Systems Technology Innovations to Drive Growth
  •  Global Electrocardiogram (ECG) Data Management Systems Market: Increasing Demand to Drive Growth
  •  Global Cardiopulmonary Stress Testing Systems: Market Opportunity Assessment and Insight to 2015
  •  Global Automated External Defibrillators (AED) Market: Demand to Drive Growth
  •  Wound Care Management Pipeline Technology and Market Forecasts to 2015
  •  Intra Ocular Lenses Pipeline Technology and Market Forecasts to 2015
  •  Cardiac Assist Devices Pipeline Technology and Market Forecasts to 2015
  •  Germany Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015
  •  India Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015
  •  Medical Equipment Mergers & Acquisitions Trends – March 2009
  •  Brazil Orthopedic Devices Market Analysis and Forecasts to 2015
  •  Medical Equipment Mergers & Acquisitions Trends – June 2009
  •  Canada Diabetes Care Devices Market Analysis and Forecasts to 2015
  •  Medical Equipment Mergers & Acquisitions Trends – July 2009
  •  UK Diabetes Care Devices Market Analysis and Forecasts to 2015
  •  Mergers & Acquisitions and Financing Trends in Medical Equipment Q2 2009
  •  Dental Radiology Equipment: Taking the Digital Path
  •  Nucleus Replacement: A New Option for Treating Degenerative Disc Disease
  •  Tissue Heart Valves: Aging Population in the US and Europe Bolstering Growth
  •  Stimulus Package to Electronic Medical Records (EMR): Collaboration Opportunities
  •  US Mammography Equipment Market: Product Innovations to Drive Growth
  •  China Medical Equipment Market Analysis and Forecasts to 2015
  • Pharma-Reports
  •  Attention Deficit Hyperactivity Disorder: Diagnosis and Treatment
  •  Bioinformatics Market Potential
  •  Biotechnology in the European Union; Trends, Investing & Country Profiles
  •  China Pharmaceutical Industry: Analysis and Market Trends
  •  European Generic Drug Market Potential
  •  Global Biotechnology Markets Trends
  •  Strategic Alliances in World Pharma and Biotech Markets
  •  Understanding China's Chemical Industry
  •  Understanding Genomics and Global Health Impacts
  •  Understanding Pharmacogenomics
  •  Understanding Stem Cell Research
  •  Understanding the Global Biotech Industry
  •  Understanding the Global Pharmaceutical Market
  • Life Science Analytics Reports
  •  Autoimmune And Inflammation Allergy Therapy Area Pipeline Report
  •  Autoimmune And Inflammation Arthritis Therapy Area Pipeline Report
  •  Autoimmune And Inflammation Autoimmune Diseases Therapy Area Pipeline Report
  •  Autoimmune And Inflammation Inflammation Therapy Area Pipeline Report
  •  Autoimmune And Inflammation Rheumatoid Arthritis Therapy Area Pipeline Report
  •  Autoimmune And Inflammation Transplant Rejection or Transplantation Therapy Area Pipeline Report
  •  Blood and Lymphatic System Anemia Therapy Area Pipeline Report
  •  Blood and Lymphatic System Dyslipidemia Therapy Area Pipeline Report
  •  Blood and Lymphatic System Electrolyte Deficiencies Therapy Area Pipeline Report
  •  Blood and Lymphatic System Hemophilia or Blood Coagulation Disorders Therapy Area Pipeline Report
  •  Blood and Lymphatic System Hemorrhage Therapy Area Pipeline Report
  •  Blood and Lymphatic System Hyperlipemia Therapy Area Pipeline Report
  •  Blood and Lymphatic System Myelodysplastic Syndrome Therapy Area Pipeline Report
  •  Blood and Lymphatic System Thrombocytopenia or Idiopathic Thrombocytopenic Purpura Therapy Area Pipeline Report
  •  Blood and Lymphatic System Thromboembolism Therapy Area Pipeline Report
  •  Cancer Acute Lymphoblastic Leukemia or Leukemia or Chronic Lymphocytic Leukemia or Chronic Myelogenous Leukemia or Acute Myelogenous Leukemia or Hairy Cell Leukemia Therapy Area Pipeline Report
  •  Cancer Bladder Cancer Therapy Area Pipeline Report
  •  Cancer Brain Tumor Therapy Area Pipeline Report
  •  Cancer Breast Cancer Therapy Area Pipeline Report
  •  Cancer Colorectal Cancer or Colon Cancer Therapy Area Pipeline Report
  •  Cancer Gastrointestinal (Stomach) Cancer Therapy Area Pipeline Report
  •  Cancer Head and Neck Cancer Therapy Area Pipeline Report
  •  Cancer Kidney Cancer Therapy Area Pipeline Report
  •  Cancer Liver Cancer Therapy Area Pipeline Report
  •  Cancer Lymphoma Therapy Area Pipeline Report
  •  Cancer Melanoma or Skin Cancer Therapy Area Pipeline Report
  •  Cancer Multiple Myeloma Therapy Area Pipeline Report
  •  Cancer Non-Hodgkin Lymphoma Therapy Area Pipeline Report
  •  Cancer Non-Small-Cell Lung Cancer or Lung Cancer or Small Cell Lung Cancer Therapy Area Pipeline Report
  •  Cancer Ovarian Cancer Therapy Area Pipeline Report
  •  Cancer Pancreatic Cancer Therapy Area Pipeline Report
  •  Cancer Prostate Cancer Therapy Area Pipeline Report
  •  Cardiovascular and Circulatory System Acute Coronary Syndromes Therapy Area Pipeline Report
  •  Cardiovascular and Circulatory System Angina Therapy Area Pipeline Report
  •  Cardiovascular and Circulatory System Atherosclerosis or Coronary Artery Disease Therapy Area Pipeline Report
  •  Cardiovascular and Circulatory System Atrial Fibrillation Therapy Area Pipeline Report
  •  Cardiovascular and Circulatory System Congestive Heart Failure Therapy Area Pipeline Report
  •  Cardiovascular and Circulatory System Edema Therapy Area Pipeline Report
  •  Cardiovascular and Circulatory System Hypercholesterolemia Therapy Area Pipeline Report
  •  Cardiovascular and Circulatory System Hypertension Therapy Area Pipeline Report
  •  Cardiovascular and Circulatory System Hypotension Therapy Area Pipeline Report
  •  Cardiovascular and Circulatory System Intermittent Claudication Therapy Area Pipeline Report
  •  Cardiovascular and Circulatory System Ischemia Therapy Area Pipeline Report
  •  Cardiovascular and Circulatory System Myocardial Infarction Therapy Area Pipeline Report
  •  Cardiovascular and Circulatory System Peripheral Vascular Disease Therapy Area Pipeline Report
  •  Cardiovascular and Circulatory System Restenosis Therapy Area Pipeline Report
  •  Cardiovascular and Circulatory System Stroke Therapy Area Pipeline Report
  •  Cardiovascular and Circulatory System Thrombosis Therapy Area Pipeline Report
  •  Cardiovascular and Circulatory System Varicose Veins Therapy Area Pipeline Report
  •  Central Nervous System Alzheimer Disease Therapy Area Pipeline Report
  •  Central Nervous System Amyotrophic Lateral Sclerosis Therapy Area Pipeline Report
  •  Central Nervous System Anxiety Therapy Area Pipeline Report
  •  Central Nervous System Attention Deficit Disorder with Hyperactivity Therapy Area Pipeline Report
  •  Central Nervous System Bipolar Disorder Therapy Area Pipeline Report
  •  Central Nervous System Dementia Therapy Area Pipeline Report
  •  Central Nervous System Depression Therapy Area Pipeline Report
  •  Central Nervous System Epilepsy Therapy Area Pipeline Report
  •  Central Nervous System Headache Therapy Area Pipeline Report
  •  Central Nervous System Huntington Disease Therapy Area Pipeline Report
  •  Central Nervous System Insomnia or Sleep Disorders Therapy Area Pipeline Report
  •  Central Nervous System Memory Impairment Therapy Area Pipeline Report
  •  Central Nervous System Migraine Therapy Area Pipeline Report
  •  Central Nervous System Multiple Sclerosis Therapy Area Pipeline Report
  •  Central Nervous System Myasthenia Gravis Therapy Area Pipeline Report
  •  Central Nervous System Neuralgia Therapy Area Pipeline Report
  •  Central Nervous System Neuropathy Therapy Area Pipeline Report
  •  Central Nervous System Obsessive-Compulsive Disorder Therapy Area Pipeline Report
  •  Central Nervous System Pain Therapy Area Pipeline Report
  •  Central Nervous System Panic Disorder Therapy Area Pipeline Report
  •  Central Nervous System Parkinson Disease Therapy Area Pipeline Report
  •  Central Nervous System Psychotic Disorders Therapy Area Pipeline Report
  •  Central Nervous System Schizophrenia Therapy Area Pipeline Report
  •  Central Nervous System Stroke Therapy Area Pipeline Report
  •  Central Nervous System Vertigo Therapy Area Pipeline Report
  •  Dental Caries Therapy Area Pipeline Report
  •  Dental Dental Pain Therapy Area Pipeline Report
  •  Dental Gingivitis or Periodontitis Therapy Area Pipeline Report
  •  Dermatology Acne Therapy Area Pipeline Report
  •  Dermatology Alopecia (Hair Loss) Therapy Area Pipeline Report
  •  Dermatology Burns Therapy Area Pipeline Report
  •  Dermatology Psoriasis Therapy Area Pipeline Report
  •  Dermatology Scabies Therapy Area Pipeline Report
  •  Dermatology Seborrheic Dermatitis Therapy Area Pipeline Report
  •  Dermatology Skin Infections or Dermatosis or Skin Itching Therapy Area Pipeline Report
  •  Dermatology Tinea Pedis (Athlete's Foot) Therapy Area Pipeline Report
  •  Dermatology Wounds or Wound Dressing Therapy Area Pipeline Report
  •  Dermatology Wrinkles Therapy Area Pipeline Report
  •  Digestive System Acidity Therapy Area Pipeline Report
  •  Digestive System Constipation Therapy Area Pipeline Report
  •  Digestive System Diarrhea Therapy Area Pipeline Report
  •  Digestive System Flatulence Therapy Area Pipeline Report
  •  Digestive System Gastroesophageal Reflux Disease Therapy Area Pipeline Report
  •  Digestive System Hemorrhoids Therapy Area Pipeline Report
  •  Digestive System Indigestion Therapy Area Pipeline Report
  •  Digestive System Inflammatory Bowel Disease Therapy Area Pipeline Report
  •  Digestive System Irritable Bowel Syndrome Therapy Area Pipeline Report
  •  Digestive System Nausea and Vomiting Therapy Area Pipeline Report
  •  Digestive System Peptic Ulcer or Gastric Ulcer or Duodenal Ulcer Therapy Area Pipeline Report
  •  Digestive System Ulcerative Colitis Therapy Area Pipeline Report
  •  Digestive System Ulcers Therapy Area Pipeline Report
  •  Genetic Diseases and Dysmorphic Syndromes Gaucher's Disease Therapy Area Pipeline Report
  •  Genetic Diseases and Dysmorphic Syndromes Turner's Syndrome Therapy Area Pipeline Report
  •  Genetic Diseases and Dysmorphic Syndromes Wilson Disease Therapy Area Pipeline Report
  •  Infections Acute Intestinal Amebiasis Therapy Area Pipeline Report
  •  Infections AIDS HIV Therapy Area Pipeline Report
  •  Infections Bacterial Infections Therapy Area Pipeline Report
  •  Infections Diphtheria Therapy Area Pipeline Report
  •  Infections Ear Infections Therapy Area Pipeline Report
  •  Infections Fever Therapy Area Pipeline Report
  •  Infections Fungal Infections or Candidiasis Therapy Area Pipeline Report
  •  Infections Helminthic Infestations Therapy Area Pipeline Report
  •  Infections Hepatitis B Therapy Area Pipeline Report
  •  Infections Hepatitis C Therapy Area Pipeline Report
  •  Infections Hepatitis Therapy Area Pipeline Report
  •  Infections Herpes Simplex Virus Infection Therapy Area Pipeline Report
  •  Infections Influenza Therapy Area Pipeline Report
  •  Infections Malaria Therapy Area Pipeline Report
  •  Infections Onychomycosis Therapy Area Pipeline Report
  •  Infections Pneumonia Therapy Area Pipeline Report
  •  Infections Sepsis Therapy Area Pipeline Report
  •  Infections Skin and Soft Tissue Infections Therapy Area Pipeline Report
  •  Infections Staphylococcal Infections Therapy Area Pipeline Report
  •  Infections Tetanus Therapy Area Pipeline Report
  •  Infections Throat Infection Therapy Area Pipeline Report
  •  Infections Tuberculosis Therapy Area Pipeline Report
  •  Infections Urinary Tract Infections Therapy Area Pipeline Report
  •  Infections Viral Infections Therapy Area Pipeline Report
  •  Kidneys and Genito-Urinary System Benign Prostatic Hyperplasia Therapy Area Pipeline Report
  •  Kidneys and Genito-Urinary System Diabetic Nephropathy Therapy Area Pipeline Report
  •  Kidneys and Genito-Urinary System Erectile Dysfunction Therapy Area Pipeline Report
  •  Kidneys and Genito-Urinary System Hyperphosphatemia Therapy Area Pipeline Report
  •  Kidneys and Genito-Urinary System Kidney Stones Therapy Area Pipeline Report
  •  Kidneys and Genito-Urinary System Overactive Bladder Therapy Area Pipeline Report
  •  Kidneys and Genito-Urinary System Urinary Incontinence Therapy Area Pipeline Report
  •  Metabolic Endocrinology Cachexia Therapy Area Pipeline Report
  •  Metabolic Endocrinology Diabetic Neuropathy Therapy Area Pipeline Report
  •  Metabolic Endocrinology Growth Hormone Deficiency Therapy Area Pipeline Report
  •  Metabolic Endocrinology Hormone Replacement Therapy Therapy Area Pipeline Report
  •  Metabolic Endocrinology Hypercalcemia Therapy Area Pipeline Report
  •  Metabolic Endocrinology Hypocalcemia Therapy Area Pipeline Report
  •  Metabolic Endocrinology Hypogonadism Therapy Area Pipeline Report
  •  Metabolic Endocrinology Obesity Therapy Area Pipeline Report
  •  Metabolic Endocrinology Type I Diabetes Therapy Area Pipeline Report
  •  Metabolic Endocrinology Type II Diabetes Therapy Area Pipeline Report
  •  Metabolic Endocrinology Vitamin Deficiency Therapy Area Pipeline Report
  •  Musculo-Skeletal-Disorders Gout Therapy Area Pipeline Report
  •  Musculo-Skeletal-Disorders Muscle Pain Therapy Area Pipeline Report
  •  Musculo-Skeletal-Disorders Osteoarthritis Therapy Area Pipeline Report
  •  Musculo-Skeletal-Disorders Osteoporosis Therapy Area Pipeline Report
  •  Musculo-Skeletal-Disorders Paget's Disease Therapy Area Pipeline Report
  •  Ophthalmology and Optometry Conjunctivitis Therapy Area Pipeline Report
  •  Ophthalmology and Optometry Diabetic Retinopathy Therapy Area Pipeline Report
  •  Ophthalmology and Optometry Dry Eye Syndrome Therapy Area Pipeline Report
  •  Ophthalmology and Optometry Eye Infections Therapy Area Pipeline Report
  •  Ophthalmology and Optometry Glaucoma Therapy Area Pipeline Report
  •  Ophthalmology and Optometry Macular Degeneration Therapy Area Pipeline Report
  •  Ophthalmology and Optometry Ocular Hypertension Therapy Area Pipeline Report
  •  Ophthalmology and Optometry Ocular Inflammation Therapy Area Pipeline Report
  •  Respiratory and Pulmonary System Asthma Therapy Area Pipeline Report
  •  Respiratory and Pulmonary System Bronchitis Therapy Area Pipeline Report
  •  Respiratory and Pulmonary System Bronchospasm Therapy Area Pipeline Report
  •  Respiratory and Pulmonary System Chronic Obstructive Pulmonary Disease Therapy Area Pipeline Report
  •  Respiratory and Pulmonary System Cough Therapy Area Pipeline Report
  •  Respiratory and Pulmonary System Cystic Fibrosis Therapy Area Pipeline Report
  •  Respiratory and Pulmonary System Nasal congestion Therapy Area Pipeline Report
  •  Respiratory and Pulmonary System Pulmonary Fibrosis Therapy Area Pipeline Report
  •  Respiratory and Pulmonary System Pulmonary Hypertension Therapy Area Pipeline Report
  •  Respiratory and Pulmonary System Respiratory Tract Infections Therapy Area Pipeline Report
  •  Substance Abuse Alcoholism Therapy Area Pipeline Report
  •  Substance Abuse Antidote Therapy Area Pipeline Report
  •  Substance Abuse Opium Addiction Therapy Area Pipeline Report
  •  Substance Abuse Poisoning Therapy Area Pipeline Report
  •  Substance Abuse Smoking Cessation Therapy Area Pipeline Report
  •  Women's Health Abnormal Uterine Bleeding Therapy Area Pipeline Report
  •  Women's Health Contraception Therapy Area Pipeline Report
  •  Women's Health Dysmenorrhea Therapy Area Pipeline Report
  •  Women's Health Endometriosis Therapy Area Pipeline Report
  •  Women's Health Female Sexual Dysfunction Therapy Area Pipeline Report
  •  Women's Health Infertility Therapy Area Pipeline Report
  •  Women's Health Labor and Delivery Therapy Area Pipeline Report
  •  Women's Health Menopausal Symptoms Therapy Area Pipeline Report
  •  Women's Health Postmenopausal Osteoporosis Therapy Area Pipeline Report
  •  Women's Health Vaginal Infections Therapy Area Pipeline Report

    • BioPortfolio uses RBS Worldpay Secure Server for credit card transactions